KR20100036961A - Novel aromatic derivatives and organic electroluminescent device comprising same - Google Patents

Novel aromatic derivatives and organic electroluminescent device comprising same Download PDF

Info

Publication number
KR20100036961A
KR20100036961A KR1020090091136A KR20090091136A KR20100036961A KR 20100036961 A KR20100036961 A KR 20100036961A KR 1020090091136 A KR1020090091136 A KR 1020090091136A KR 20090091136 A KR20090091136 A KR 20090091136A KR 20100036961 A KR20100036961 A KR 20100036961A
Authority
KR
South Korea
Prior art keywords
formula
compound
alkyl
aryl
heteroaryl
Prior art date
Application number
KR1020090091136A
Other languages
Korean (ko)
Other versions
KR101142056B1 (en
Inventor
이칠원
유선근
김준우
이은정
임일지
Original Assignee
대주전자재료 주식회사
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 대주전자재료 주식회사 filed Critical 대주전자재료 주식회사
Publication of KR20100036961A publication Critical patent/KR20100036961A/en
Application granted granted Critical
Publication of KR101142056B1 publication Critical patent/KR101142056B1/en

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C13/00Cyclic hydrocarbons containing rings other than, or in addition to, six-membered aromatic rings
    • C07C13/28Polycyclic hydrocarbons or acyclic hydrocarbon derivatives thereof
    • C07C13/32Polycyclic hydrocarbons or acyclic hydrocarbon derivatives thereof with condensed rings
    • C07C13/72Spiro hydrocarbons
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C13/00Cyclic hydrocarbons containing rings other than, or in addition to, six-membered aromatic rings
    • C07C13/28Polycyclic hydrocarbons or acyclic hydrocarbon derivatives thereof
    • C07C13/32Polycyclic hydrocarbons or acyclic hydrocarbon derivatives thereof with condensed rings
    • C07C13/62Polycyclic hydrocarbons or acyclic hydrocarbon derivatives thereof with condensed rings with more than three condensed rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C205/00Compounds containing nitro groups bound to a carbon skeleton
    • C07C205/06Compounds containing nitro groups bound to a carbon skeleton having nitro groups bound to carbon atoms of six-membered aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C211/00Compounds containing amino groups bound to a carbon skeleton
    • C07C211/43Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
    • C07C211/57Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton having amino groups bound to carbon atoms of six-membered aromatic rings being part of condensed ring systems of the carbon skeleton
    • C07C211/61Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton having amino groups bound to carbon atoms of six-membered aromatic rings being part of condensed ring systems of the carbon skeleton with at least one of the condensed ring systems formed by three or more rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C6/00Preparation of hydrocarbons from hydrocarbons containing a different number of carbon atoms by redistribution reactions
    • C07C6/08Preparation of hydrocarbons from hydrocarbons containing a different number of carbon atoms by redistribution reactions by conversion at a saturated carbon-to-carbon bond
    • C07C6/12Preparation of hydrocarbons from hydrocarbons containing a different number of carbon atoms by redistribution reactions by conversion at a saturated carbon-to-carbon bond of exclusively hydrocarbons containing a six-membered aromatic ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/06Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom containing only hydrogen and carbon atoms in addition to the ring nitrogen atom
    • C07D213/16Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom containing only hydrogen and carbon atoms in addition to the ring nitrogen atom containing only one pyridine ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/50Organo-phosphines
    • C07F9/5022Aromatic phosphines (P-C aromatic linkage)
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/50Organo-phosphines
    • C07F9/53Organo-phosphine oxides; Organo-phosphine thioxides
    • C07F9/5325Aromatic phosphine oxides or thioxides (P-C aromatic linkage)
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K11/00Luminescent, e.g. electroluminescent, chemiluminescent materials
    • C09K11/06Luminescent, e.g. electroluminescent, chemiluminescent materials containing organic luminescent materials
    • HELECTRICITY
    • H05ELECTRIC TECHNIQUES NOT OTHERWISE PROVIDED FOR
    • H05BELECTRIC HEATING; ELECTRIC LIGHT SOURCES NOT OTHERWISE PROVIDED FOR; CIRCUIT ARRANGEMENTS FOR ELECTRIC LIGHT SOURCES, IN GENERAL
    • H05B33/00Electroluminescent light sources
    • H05B33/12Light sources with substantially two-dimensional radiating surfaces
    • H05B33/14Light sources with substantially two-dimensional radiating surfaces characterised by the chemical or physical composition or the arrangement of the electroluminescent material, or by the simultaneous addition of the electroluminescent material in or onto the light source
    • HELECTRICITY
    • H10SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10KORGANIC ELECTRIC SOLID-STATE DEVICES
    • H10K50/00Organic light-emitting devices
    • HELECTRICITY
    • H10SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10KORGANIC ELECTRIC SOLID-STATE DEVICES
    • H10K85/00Organic materials used in the body or electrodes of devices covered by this subclass
    • H10K85/60Organic compounds having low molecular weight
    • H10K85/615Polycyclic condensed aromatic hydrocarbons, e.g. anthracene
    • H10K85/626Polycyclic condensed aromatic hydrocarbons, e.g. anthracene containing more than one polycyclic condensed aromatic rings, e.g. bis-anthracene
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/06Systems containing only non-condensed rings with a five-membered ring
    • C07C2601/08Systems containing only non-condensed rings with a five-membered ring the ring being saturated
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2603/00Systems containing at least three condensed rings
    • C07C2603/02Ortho- or ortho- and peri-condensed systems
    • C07C2603/04Ortho- or ortho- and peri-condensed systems containing three rings
    • C07C2603/22Ortho- or ortho- and peri-condensed systems containing three rings containing only six-membered rings
    • C07C2603/24Anthracenes; Hydrogenated anthracenes
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2603/00Systems containing at least three condensed rings
    • C07C2603/02Ortho- or ortho- and peri-condensed systems
    • C07C2603/04Ortho- or ortho- and peri-condensed systems containing three rings
    • C07C2603/22Ortho- or ortho- and peri-condensed systems containing three rings containing only six-membered rings
    • C07C2603/26Phenanthrenes; Hydrogenated phenanthrenes
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2603/00Systems containing at least three condensed rings
    • C07C2603/02Ortho- or ortho- and peri-condensed systems
    • C07C2603/40Ortho- or ortho- and peri-condensed systems containing four condensed rings
    • C07C2603/42Ortho- or ortho- and peri-condensed systems containing four condensed rings containing only six-membered rings
    • C07C2603/50Pyrenes; Hydrogenated pyrenes
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2603/00Systems containing at least three condensed rings
    • C07C2603/02Ortho- or ortho- and peri-condensed systems
    • C07C2603/52Ortho- or ortho- and peri-condensed systems containing five condensed rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2603/00Systems containing at least three condensed rings
    • C07C2603/02Ortho- or ortho- and peri-condensed systems
    • C07C2603/54Ortho- or ortho- and peri-condensed systems containing more than five condensed rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2603/00Systems containing at least three condensed rings
    • C07C2603/93Spiro compounds
    • C07C2603/94Spiro compounds containing "free" spiro atoms
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K2211/00Chemical nature of organic luminescent or tenebrescent compounds
    • C09K2211/10Non-macromolecular compounds
    • C09K2211/1003Carbocyclic compounds
    • C09K2211/1011Condensed systems
    • HELECTRICITY
    • H10SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10KORGANIC ELECTRIC SOLID-STATE DEVICES
    • H10K2102/00Constructional details relating to the organic devices covered by this subclass
    • H10K2102/10Transparent electrodes, e.g. using graphene
    • H10K2102/101Transparent electrodes, e.g. using graphene comprising transparent conductive oxides [TCO]
    • H10K2102/103Transparent electrodes, e.g. using graphene comprising transparent conductive oxides [TCO] comprising indium oxides, e.g. ITO
    • HELECTRICITY
    • H10SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10KORGANIC ELECTRIC SOLID-STATE DEVICES
    • H10K50/00Organic light-emitting devices
    • H10K50/10OLEDs or polymer light-emitting diodes [PLED]
    • H10K50/11OLEDs or polymer light-emitting diodes [PLED] characterised by the electroluminescent [EL] layers
    • HELECTRICITY
    • H10SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10KORGANIC ELECTRIC SOLID-STATE DEVICES
    • H10K85/00Organic materials used in the body or electrodes of devices covered by this subclass
    • H10K85/30Coordination compounds
    • H10K85/321Metal complexes comprising a group IIIA element, e.g. Tris (8-hydroxyquinoline) gallium [Gaq3]
    • H10K85/324Metal complexes comprising a group IIIA element, e.g. Tris (8-hydroxyquinoline) gallium [Gaq3] comprising aluminium, e.g. Alq3
    • HELECTRICITY
    • H10SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10KORGANIC ELECTRIC SOLID-STATE DEVICES
    • H10K85/00Organic materials used in the body or electrodes of devices covered by this subclass
    • H10K85/60Organic compounds having low molecular weight
    • H10K85/631Amine compounds having at least two aryl rest on at least one amine-nitrogen atom, e.g. triphenylamine
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02EREDUCTION OF GREENHOUSE GAS [GHG] EMISSIONS, RELATED TO ENERGY GENERATION, TRANSMISSION OR DISTRIBUTION
    • Y02E10/00Energy generation through renewable energy sources
    • Y02E10/50Photovoltaic [PV] energy
    • Y02E10/549Organic PV cells

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Optics & Photonics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Electroluminescent Light Sources (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

PURPOSE: A compound is provided to ensure excellent heat resistance and thin film stability and to improve driving stability, luminous efficiency, color purity and lifetime property of an organic electroluminescent device. CONSTITUTION: A compound is represented by chemical formula (I), wherein Ri and R2 are each independently hydrogen, C1-50 alkyl, C3-50 cycloalkyl, C6-50 aryl, or heteroaryl having 5 to 50 ring atoms, Ri or R2 being optionally substituted with Ci-50 alkyl, C6-5O aryl, heteroaryl having 5 to 50 ring atoms, or C7-50 aralkyl, or Ri and R2 being optionally linked to form a C4-50 saturated or unsaturated ring moiety; Ar is an aromatic hydrocarbon moiety, optionally substituted with X, the aromatic hydrocarbon group being a fused ring of at least two benzenes; R3 and X are each independently hydrogen, halogen, cyano, nitro, amino, thio, phosphoryl, phosphinyl, carbonyl, silyl, boranyl, Ci-50 alkyl, C2-5O alkenyl, C2-50 alkynyl, Ci-50 alkoxy, C3-50 cycloalkyl, C6-50 aryl, or heteroaryl having 5 to 50 ring atoms; R3 or X being optionally substituted with amino, thio, phosphoryl, phosphinyl, carbonyl, silyl, boranyl, Ci-50 alkyl, C2-50 alkenyl, C2-50 alkynyl, Ci-50 alkoxy, C3-50 cycloalkyl, C6-50 aryl, or heteroaryl having 5 to 50 ring atoms, or C7-50 aralkyl, which optionally has a C^6 alkyl substituent, or each of R3 and X being optionally linked together with its adjacent group to form a C4-50 saturated or unsaturated ring moiety, with the proviso that X cannot be hydrogen; and n is an integer of 1 to 6.

Description

신규한 방향족 유도체 및 이를 포함하는 유기전기발광소자{NOVEL AROMATIC DERIVATIVES AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING SAME}Novel aromatic derivatives and organic electroluminescent devices comprising the same {NOVEL AROMATIC DERIVATIVES AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING SAME}

본 발명은 발광 효율 및 내열성 등이 우수한 신규한 방향족 유도체 및 이를 하나 이상의 유기층에 포함함으로써 우수한 수명 특성을 나타내고 저전압구동이 가능한 유기전기발광소자에 관한 것이다. The present invention relates to a novel aromatic derivative having excellent luminous efficiency, heat resistance and the like and an organic electroluminescent device capable of exhibiting excellent lifespan characteristics and low voltage driving by including the same in one or more organic layers.

유기전기발광소자는 자기발광형 발광소자로, 타 평판 표시소자에 비해 구조가 단순하여 제조 공정이 간단하고, 높은 휘도 및 우수한 시야각 특성을 가지며, 응답속도가 빠르고 구동전압이 낮아, 벽걸이 TV 등의 평판 디스플레이 또는 디스플레이의 배면광, 조명, 광고판 등의 광원으로서 응용성을 보이고 있다. 유기 전기발광 현상은 1969년 쿠르니(Curnee)에 의해서 공지(US 특허 제3,172,862호)된 이래 실용적인 측면에서 한계를 보여 왔으나, 1987년 이스트만 코닥사의 연구진에 의해서 기존의 문제점을 극복한 유기전기발광소자가 개발됨에 따라 이후 급속히 발전되어 왔다. The organic electroluminescent device is a self-luminous type light emitting device. The structure is simpler than other flat panel display devices, and thus the manufacturing process is simple, has high luminance and excellent viewing angle characteristics, fast response speed and low driving voltage, Applicability is shown as a light source of a flat panel display or a back light of a display, an illumination, an advertisement board, etc. The organic electroluminescence phenomenon has been limited in practical terms since it was announced by Curnee in 1969 (US Pat. No. 3,172,862), but in 1987, an organic electroluminescent device was overcome by the researchers of Eastman Kodak. Has developed rapidly since then.

일반적으로, 유기전기발광소자는 음극(전자주입전극)과 양극(정공주입전극), 및 상기 두 전극 사이에 하나 이상의 유기층을 포함하는 구조를 갖는다. 이때, 유기전기발광소자는 유기층으로서 발광층(EML, light emitting layer) 이외에, 정공주입층(HIL, hole injection layer), 정공수송층(HTL, hole transport layer), 전자수송층(ETL, electron transport layer) 또는 전자주입층(EIL, electron injection layer)을 포함할 수 있으며, 발광층의 발광특성상, 전자차단층(EBL, electron blocking layer) 또는 정공차단층(HBL, hole blocking layer)을 추가로 포함할 수 있다. 이들 유기층을 모두 포함하는 유기전기발광소자는 양극/정공주입층/정공수송층/전자차단층/발광층/정공차단층/전자수송층/전자주입층/음극 순으로 적층된 구조를 갖는다.In general, the organic electroluminescent device has a structure including a cathode (electron injection electrode) and an anode (hole injection electrode), and at least one organic layer between the two electrodes. In this case, the organic electroluminescent device may be a hole injection layer (HIL), a hole transport layer (HTL), an electron transport layer (ETL), in addition to the light emitting layer (EML) as an organic layer. It may include an electron injection layer (EIL), and may further include an electron blocking layer (EBL) or a hole blocking layer (HBL) due to light emission characteristics of the light emitting layer. The organic electroluminescent device including all of these organic layers has a structure laminated in the order of anode / hole injection layer / hole transport layer / electron blocking layer / light emitting layer / hole blocking layer / electron transport layer / electron injection layer / cathode.

이러한 구조의 유기전기발광소자에 전기장을 인가하면, 양극으로부터 주입된 정공과 음극으로부터 주입된 전자가 재결합(recombination)하여 전자-정공 쌍인 엑시톤(exiton)을 형성하며, 이 엑시톤의 에너지가 발광 재료에 전달됨에 따라 빛이 방출된다. 적층형 유기전기발광소자의 수명은 재료의 전기화학적 안정성 및 박막 안정성 등과 관련이 깊다.When an electric field is applied to the organic electroluminescent device of this structure, holes injected from the anode and electrons injected from the cathode are recombined to form an exciton, an electron-hole pair, and the energy of the excitons is applied to the light emitting material. As it is transmitted, light is emitted. The lifetime of stacked organic electroluminescent devices is related to the electrochemical stability and thin film stability of materials.

예컨대, 열안정성이 좋지 않은 발광 물질을 사용할 경우에는 고온 또는 구동온도에서 상기 재료의 결정화가 이루어져 소자의 수명이 단축된다. 안트라센 유도체는 대표적인 유기 전기발광 소자용 재료로 발광층을 비롯하여 정공수송층 및 전자수송층 등에 이용되어 왔다. 일례로 9,10-다이(나프탈렌-2-일)안트라센의 경우 발광특성이 매우 우수하여 청색 호스트 재료로 이용하고 있으나, 소자의 온도가 상 승함에 따라 쉽게 결정화되어 소자의 수명이 짧은 단점이 있다. 열적 안정성을 확보하기 위해 방향족 고리화합물을 탄소로 연결한 형태의 플루오렌 유도체나 벤조플루오렌 유도체 등이 개발되었으나, 밴드갭이 넓어 청색 호스트 재료로서 사용하기에 구동전압 측면이나 도판트로의 에너지 전이 등의 문제가 발생하였다. 이러한 단점을 극복하기 위해서 다양한 형태의 재료가 개발되고 있으나, 현재까지는 요구되는 발광효율, 구동 안정성, 그리고 수명 등의 특성을 충분히 만족하지 못하고 있는 실정이어서 다양한 기술개발이 시급하다. For example, when a light emitting material having poor thermal stability is used, the material is crystallized at a high temperature or a driving temperature, thereby shortening the life of the device. Anthracene derivatives have been used as typical organic electroluminescent device materials, including light emitting layers, hole transport layers and electron transport layers. For example, 9,10-di (naphthalen-2-yl) anthracene is used as a blue host material because of its excellent luminescence properties, but it has a disadvantage of shortening the life of the device because it is easily crystallized as the temperature of the device rises. . In order to secure thermal stability, fluorene derivatives and benzofluorene derivatives in which carbons are linked to aromatic cyclic compounds have been developed, but because of their wide bandgap, they can be used as blue host materials for driving voltage and energy transfer to dopants. A problem occurred. In order to overcome these drawbacks, various types of materials have been developed, but until now, various technologies have been urgently developed because they do not sufficiently satisfy characteristics such as luminous efficiency, driving stability, and lifetime.

따라서, 본 발명의 목적은 우수한 내열성 및 박막 안정성을 가져 유기전기발광소자의 구동 안정성, 발광효율, 색순도 및 수명 특성을 현저히 개선시킬 수 있는 신규한 화합물, 및 이를 유기층에 포함하는 유기전기발광소자를 제공하는 것이다.Accordingly, an object of the present invention is to provide a novel compound having excellent heat resistance and thin film stability, which can significantly improve driving stability, luminous efficiency, color purity, and lifetime characteristics of an organic electroluminescent device, and an organic electroluminescent device comprising the same in an organic layer. To provide.

상기 목적을 달성하기 위하여 본 발명은 하기 화학식 1로 표시되는 방향족 유도체를 제공한다:In order to achieve the above object, the present invention provides an aromatic derivative represented by the following formula (1):

Figure 112009059119266-PAT00001
Figure 112009059119266-PAT00001

상기 식에서,Where

R1 및 R2는 각각 독립적으로 수소, C1-50 알킬, C3-50 사이클로알킬, C6-50 아릴 또는 핵 원자수 5 내지 50개의 헤테로아릴이고, 상기 R1 내지 R2는 임의적으로 C1-50 알킬, C6-50 아릴, 핵 원자수 5 내지 50개의 헤테로아릴 또는 C7-50 아르알킬로 치환될 수 있고, R1과 R2는 임의적으로 서로 결합하여 C4-50 포화 고리 또는 불포화 고리를 형성할 수 있고;R 1 and R 2 are each independently hydrogen, C 1-50 alkyl, C 3-50 cycloalkyl, C 6-50 aryl or heteroaryl having 5 to 50 nuclear atoms, wherein R 1 to R 2 are optionally C 1-50 alkyl, C 6-50 aryl, 5 to 50 heteroaryl or C 7-50 aralkyl may be substituted, and R 1 and R 2 are optionally bonded to each other to C 4-50 saturated May form a ring or an unsaturated ring;

Ar은 X로 치환되거나 치환되지 않은, 2개 이상의 벤젠 고리가 접합된 방향족 탄화수소이고;Ar is an aromatic hydrocarbon having two or more benzene rings conjugated or unsubstituted by X;

R3 및 X는 각각 독립적으로 수소, 할로겐, 시아노, 니트로, 아미노, 싸이오, 포스포릴, 포스피닐, 카보닐, 실릴, 보란일, C1-50 알킬, C2-50 알케닐, C2-50 알키닐, C1-50 알콕시, C3-50 사이클로알킬, C6-50 아릴 또는 핵 원자수 5 내지 50개의 헤테로아릴이고(단 X는 수소가 아님), 상기 R3 및 X는 임의적으로 C1-6 알킬로 치환되거나 치환되지 않은, 아미노, 싸이오, 포스포릴, 포스피닐, 카보닐, 실릴, 보란일, C1-50 알킬, C2-50 알케닐, C2-50 알키닐, C1-50 알콕시, C3-50 사이클로알킬, C6-50 아릴, 핵 원자수 5 내지 50개의 헤테로아릴 또는 C7-50 아르알킬로 치환될 수 있고, R3 및 X 각각은 인접한 기와 임의적으로 서로 결합하여 C4-50 포화 고리 또는 불포화 고리를 형성할 수 있고;R 3 and X are each independently hydrogen, halogen, cyano, nitro, amino, thio, phosphoryl, phosphinyl, carbonyl, silyl, boranyl, C 1-50 alkyl, C 2-50 alkenyl, C 2-50 alkynyl, C 1-50 alkoxy, C 3-50 cycloalkyl, C 6-50 aryl or heteroaryl having 5 to 50 nuclear atoms (where X is not hydrogen), wherein R 3 and X are Amino, thio, phosphoryl, phosphinyl, carbonyl, silyl, boranyl, C 1-50 alkyl, C 2-50 alkenyl, C 2-50 , optionally substituted with C 1-6 alkyl Alkynyl, C 1-50 alkoxy, C 3-50 cycloalkyl, C 6-50 aryl, 5 to 50 heteroaryl or C 7-50 aralkyl, and each of R 3 and X is Optionally combine with adjacent groups to form a C 4-50 saturated ring or unsaturated ring;

n은 1 내지 6의 정수이다.n is an integer of 1-6.

또한, 본 발명은 상기 화학식 1의 화합물을 하나 이상의 유기층에 포함하는 유기전기발광소자를 제공한다.In addition, the present invention provides an organic electroluminescent device comprising the compound of Formula 1 in at least one organic layer.

본 발명의 방향족 유도체를 사용하는 유기전기발광소자는 내열성이 우수하고, 소자를 구성하는 박막의 안정성이 높아 수명이 길며, 색순도 및 발광효율이 높고, 저전압구동이 가능하다. 이로 인해, 본 발명의 유기전기발광소자는 벽걸이 TV 등의 평판 디스플레이, 조명 또는 디스플레이의 배면광 등에 다양하게 사용될 수 있다.The organic electroluminescent device using the aromatic derivative of the present invention has excellent heat resistance, high stability of the thin film constituting the device, long life, high color purity and luminous efficiency, and low voltage driving. For this reason, the organic electroluminescent device of the present invention can be used in various ways such as a flat panel display such as a wall-mounted TV, lighting or a backlight of a display.

본 발명에서는 플루오렌 및 벤조플루오렌의 단점인 넓은 밴드갭을 줄이고 구조적인 안정성을 도모하기 위해, 나프탈렌과 연결되는 방향족 고리 화합물로서 두 개 이상의 벤젠 고리가 접합된 화합물을 도입하고 상기 나프탈렌과 상기 방향족 고 리 화합물을 5원 고리가 아닌 6원 고리의 형태로 연결하였다. In the present invention, in order to reduce the wide bandgap which is a disadvantage of fluorene and benzofluorene and to promote structural stability, an aromatic ring compound connected with naphthalene is introduced, and a compound in which two or more benzene rings are conjugated is introduced and the naphthalene and the aromatic The ring compounds were linked in the form of six membered rings, not five membered rings.

상기 화학식 1의 화합물에서, 상기 Ar은 바람직하게는 X로 치환되거나 치환되지 않은, 나프탈렌, 안트라센, 페난트렌 또는 파이렌일 수 있다. In the compound of Formula 1, Ar may be naphthalene, anthracene, phenanthrene or pyrene, preferably substituted with X.

상기 화학식 1로 표시되는 방향족 유도체는 대표적인 예로서 하기 화학식 1a 내지 1h로 나타내어질 수 있다:The aromatic derivative represented by Formula 1 may be represented by the following Formula 1a to 1h as a representative example:

Figure 112009059119266-PAT00002
Figure 112009059119266-PAT00002

Figure 112009059119266-PAT00003
Figure 112009059119266-PAT00003

Figure 112009059119266-PAT00004
Figure 112009059119266-PAT00004

Figure 112009059119266-PAT00005
Figure 112009059119266-PAT00005

Figure 112009059119266-PAT00006
Figure 112009059119266-PAT00006

Figure 112009059119266-PAT00007
Figure 112009059119266-PAT00007

Figure 112009059119266-PAT00008
Figure 112009059119266-PAT00008

Figure 112009059119266-PAT00009
Figure 112009059119266-PAT00009

상기 식에서,Where

R1 내지 R3, X 및 n은 상기에서 정의한 바와 같고;R 1 to R 3 , X and n are as defined above;

m은 1 내지 6의 정수이고;m is an integer from 1 to 6;

z는 1 내지 8의 정수이다.z is an integer from 1 to 8.

더욱 구체적으로, 이하에서 본 발명의 화학식 1로 표시되는 방향족 유도체를 화합물 1 내지 383으로서 예시하지만, 본 발명이 이들 대표예로 한정되는 것은 아니다.More specifically, the aromatic derivative represented by the formula (1) of the present invention is exemplified below as compounds 1 to 383, but the present invention is not limited to these representative examples.

Figure 112009059119266-PAT00010
Figure 112009059119266-PAT00010

Figure 112009059119266-PAT00011
Figure 112009059119266-PAT00011

Figure 112009059119266-PAT00012
Figure 112009059119266-PAT00012

Figure 112009059119266-PAT00013
Figure 112009059119266-PAT00013

Figure 112009059119266-PAT00014
Figure 112009059119266-PAT00014

Figure 112009059119266-PAT00015
Figure 112009059119266-PAT00015

Figure 112009059119266-PAT00016
Figure 112009059119266-PAT00016

Figure 112009059119266-PAT00017
Figure 112009059119266-PAT00017

Figure 112009059119266-PAT00018
Figure 112009059119266-PAT00018

Figure 112009059119266-PAT00019
Figure 112009059119266-PAT00019

본 발명에 따른 화학식 1의 화합물은 하기 반응식 1 (R3가 수소인 경우), 반응식 2, 3 또는 4 (R3가 수소가 아닌 경우)에 나타낸 바와 같이 제조될 수 있다.Compounds of formula 1 according to the invention can be prepared as shown in Scheme 1 (where R 3 is hydrogen), schemes 2, 3 or 4 (when R 3 is not hydrogen).

Figure 112009059119266-PAT00020
Figure 112009059119266-PAT00020

Figure 112009059119266-PAT00021
Figure 112009059119266-PAT00021

Figure 112009059119266-PAT00022
Figure 112009059119266-PAT00022

Figure 112009059119266-PAT00023
Figure 112009059119266-PAT00023

상기 식에서,Where

R1, R2 및 Ar은 상기에서 정의한 바와 같고;R 1 , R 2 and Ar are as defined above;

R3' 및 R3"는 각각 독립적으로 상기 R3의 정의와 동일하되, 단 수소가 아니고;R 3 ′ and R 3 ″ are each independently the same as defined above for R 3 , provided that they are not hydrogen;

X1 및 X2는 각각 독립적으로 트리플루오로메탄설포닐 또는 할로겐이고;X 1 and X 2 are each independently trifluoromethanesulfonyl or halogen;

X3는 할로겐이고;X 3 is halogen;

Y1 및 Y2는 각각 독립적으로 수소 또는 C1-6 알킬이고, Y1 및 Y2는 서로 결합하여 고리를 형성할 수 있다.Y 1 and Y 2 are each independently hydrogen or C 1-6 alkyl, and Y 1 and Y 2 may be bonded to each other to form a ring.

상기 반응식 1에서, 유기용매(예: 톨루엔, 테트라하이드로퓨란, 에탄올 또는 이들의 혼합물)와 물의 혼합용매 중에서 화학식 2의 화합물을 화학식 3의 화합물과 반응시켜 화학식 4의 화합물을 제조한 후, 이 화학식 4의 화합물을 유기용매(예: 테트라하이드로퓨란, 에틸에테르, 1,4-다이옥산, 1,2-다이메톡시에탄 또는 이들의 혼합물) 중에서 염기(예: n-뷰틸리튬, t-뷰틸리튬 등의 강염기) 존재 하에 화학식 5의 화합물과 반응시켜 화학식 6의 화합물을 제조한 다음, 이 화학식 6의 화합물을 산(예: 염산, 질산, 황산, 보론트리플루오라이드 등의 루이스산) 존재 하에서 고리형성 반응을 시킴으로써 화학식 1i의 화합물을 제조할 수 있다. 이때, 화학식 2의 화합물과 화학식 3의 화합물과의 반응은 25 내지 110℃에서, 화학식 4의 화합물과 화학식 5의 화합물과의 반응은 -78 내지 50℃에서, 화학식 6의 화합물의 고리형성 반응은 25 내지 110℃에서 수행할 수 있다. 또한, 화학식 2의 화합물과 화학식 3의 화합물과의 반응시 염기와 촉매를 첨가하는 것이 바람직한데, 상기 염기 로는 탄산칼륨, 탄산나트륨 또는 이들의 혼합물을 사용할 수 있으며, 촉매로는 다양한 팔라듐 착물을 이용하는데 대표적으로는 테트라키스(트리페닐포스핀)팔라듐(0)을 사용할 수 있다. In Scheme 1, a compound of Formula 2 is prepared by reacting a compound of Formula 2 with a compound of Formula 3 in a mixed solvent of an organic solvent (for example, toluene, tetrahydrofuran, ethanol, or a mixture thereof), and then the compound of Formula 4 Compound 4 is dissolved in an organic solvent (e.g., tetrahydrofuran, ethyl ether, 1,4-dioxane, 1,2-dimethoxyethane, or mixtures thereof), such as n -butyllithium, t -butyllithium, etc. To react with a compound of formula (5) in the presence of a compound of formula (5), and then cyclize the compound of formula (6) in the presence of an acid (e.g., Lewis acid such as hydrochloric acid, nitric acid, sulfuric acid, By reacting, the compound of Formula 1i may be prepared. In this case, the reaction between the compound of Formula 2 and the compound of Formula 3 is at 25 to 110 ° C, the reaction of the compound of Formula 4 to the compound of Formula 5 is -78 to 50 ° C, and the cyclization reaction of the compound of Formula 6 is It may be carried out at 25 to 110 ℃. In addition, it is preferable to add a base and a catalyst in the reaction of the compound of Formula 2 with the compound of Formula 3, and as the base, potassium carbonate, sodium carbonate or a mixture thereof may be used, and various palladium complexes may be used as catalysts. Typically, tetrakis (triphenylphosphine) palladium (0) can be used.

상기 반응식 2에서는, 상기 반응식 1에서 제조된 화학식 1i의 화합물을 유기용매(예: 사염화탄소, 클로로폼, 염화메틸렌 및 이들의 혼합물) 중에서 (X3)2와 반응시켜 화학식 7의 화합물을 제조한 후, 이 화학식 7의 화합물을 유기용매(예: 톨루엔, 테트라하이드로퓨란, 에탄올 또는 이들의 혼합물)와 물의 혼합용매 중에서 화학식 8의 화합물과 반응시킴으로써 화학식 1j의 화합물을 제조할 수 있다. 이때, 화학식 1i의 화합물과 (X3)2와의 반응은 -30 내지 60℃에서, 화학식 7의 화합물과 화학식 8의 화합물과의 반응은 25 내지 110℃에서 수행할 수 있다. 또한, 화학식 7의 화합물과 화학식 8의 화합물과의 반응시 염기와 촉매를 첨가하는 것이 바람직한데, 상기 염기로는 탄산칼륨, 탄산나트륨 또는 이들의 혼합물을 사용할 수 있으며, 촉매로는 다양한 팔라듐 착물을 이용하는데 대표적으로는 테트라키스(트리페닐포스핀)팔라듐(0)을 사용할 수 있다. In Scheme 2, the compound of Formula 1i prepared in Scheme 1 is reacted with (X 3 ) 2 in an organic solvent (eg, carbon tetrachloride, chloroform, methylene chloride, and mixtures thereof) to prepare a compound of Formula 7 The compound of formula 1j may be prepared by reacting the compound of formula 7 with a compound of formula 8 in a mixed solvent of an organic solvent (eg, toluene, tetrahydrofuran, ethanol or a mixture thereof) and water. In this case, the reaction of the compound of Formula 1i with (X 3 ) 2 may be performed at −30 to 60 ° C., and the reaction of the compound of Formula 7 to the compound of Formula 8 may be performed at 25 to 110 ° C. In addition, it is preferable to add a base and a catalyst in the reaction of the compound of Formula 7 with the compound of Formula 8, and as the base, potassium carbonate, sodium carbonate or a mixture thereof may be used, and various palladium complexes may be used as the catalyst. Typically, tetrakis (triphenylphosphine) palladium (0) can be used.

상기 반응식 3에서는, 유기용매(예: 톨루엔, 테트라하이드로퓨란, 에탄올 또는 이들의 혼합물)와 물의 혼합용매 중에서 화학식 9의 화합물을 화학식 10의 화합물과 반응시켜 화학식 11의 화합물을 제조한 후, 이 화학식 11의 화합물을 유기용매(예: 테트라하이드로퓨란, 에틸에테르, 1,4-다이옥산, 1,2-다이메톡시에탄 또는 이들의 혼합물) 중에서 염기(예: n-뷰틸리튬, t-뷰틸리튬 등의 강염기) 존재 하 에 화학식 5의 화합물과 반응시켜 화학식 12의 화합물을 제조한 다음, 이 화학식 12의 화합물을 산(예: 염산, 질산, 황산, 보론트리플루오라이드 등의 루이스산) 존재 하에서 고리형성 반응을 시킴으로써 화학식 1k의 화합물을 제조할 수 있다. 이때, 화학식 9의 화합물과 화학식 10의 화합물과의 반응은 25 내지 110℃에서, 화학식 11의 화합물과 화학식 5의 화합물과의 반응은 -78 내지 50℃에서, 화학식 12의 화합물의 고리형성 반응은 25 내지 110℃에서 수행할 수 있다. 또한, 화학식 9의 화합물과 화학식 10의 화합물과의 반응시 염기와 촉매를 첨가하는 것이 바람직한데, 상기 염기로는 탄산칼륨, 탄산나트륨 또는 이들의 혼합물을 사용할 수 있으며, 촉매로는 다양한 팔라듐 착물을 이용하는데 대표적으로는 테트라키스(트리페닐포스핀)팔라듐(0)을 사용할 수 있다. In Scheme 3, a compound of Formula 9 is reacted with a compound of Formula 10 in a mixed solvent of an organic solvent (for example, toluene, tetrahydrofuran, ethanol, or a mixture thereof) to prepare a compound of Formula 11, and then 11 compound in an organic solvent (e.g., tetrahydrofuran, ethyl ether, 1,4-dioxane, 1,2-dimethoxyethane, or mixtures thereof), such as n -butyllithium, t -butyllithium, etc. To react with a compound of formula (5) in the presence of an acid (e.g., hydrochloric acid, nitric acid, sulfuric acid, boric trifluoride, etc.) The compound of formula 1k can be prepared by the formation reaction. In this case, the reaction between the compound of Formula 9 and the compound of Formula 10 is at 25 to 110 ° C, the reaction of the compound of Formula 11 to the compound of Formula 5 is -78 to 50 ° C, and the cyclization reaction of the compound of Formula 12 is It may be carried out at 25 to 110 ℃. In addition, it is preferable to add a base and a catalyst in the reaction of the compound of Formula 9 with the compound of Formula 10. As the base, potassium carbonate, sodium carbonate or a mixture thereof can be used, and various palladium complexes can be used as the catalyst. Typically, tetrakis (triphenylphosphine) palladium (0) can be used.

상기 반응식 4에서는, 상기 반응식 3에서 제조된 화학식 1k의 화합물을 유기용매(예: 사염화탄소, 클로로폼, 염화메틸렌 및 이들의 혼합물) 중에서 (X3)2와 반응시켜 화학식 13의 화합물을 제조한 후, 이 화학식 13의 화합물을 유기용매(예: 톨루엔, 테트라하이드로퓨란, 에탄올 또는 이들의 혼합물)와 물의 혼합용매 중에서 화학식 14의 화합물과 반응시킴으로써 화학식 1l의 화합물을 제조할 수 있다. 이때, 화학식 1k의 화합물과 (X3)2와의 반응은 -30 내지 60℃에서, 화학식 13의 화합물과 화학식 14의 화합물과의 반응은 25 내지 110℃에서 수행할 수 있다. 또한, 화학식 13의 화합물과 화학식 14의 화합물과의 반응시 염기와 촉매를 첨가하는 것이 바람직한데, 상기 염기로는 탄산칼륨, 탄산나트륨 또는 이들의 혼합물을 사용할 수 있으며, 촉매로는 다양한 팔라듐 착물을 이용하는데 대표적으로는 테트라키스(트리페닐포스핀)팔라듐(0)을 사용할 수 있다. In Scheme 4, the compound of Formula 1k prepared in Scheme 3 is reacted with (X 3 ) 2 in an organic solvent (eg, carbon tetrachloride, chloroform, methylene chloride, and mixtures thereof) to prepare a compound of Formula 13, In addition, the compound of Formula 1 may be prepared by reacting the compound of Formula 13 with the compound of Formula 14 in a mixed solvent of an organic solvent (eg, toluene, tetrahydrofuran, ethanol or a mixture thereof) and water. In this case, the reaction of the compound of Formula 1k and (X 3 ) 2 may be performed at -30 to 60 ° C, and the reaction of the compound of Formula 13 and the compound of Formula 14 may be performed at 25 to 110 ° C. In addition, it is preferable to add a base and a catalyst in the reaction of the compound of Formula 13 with the compound of Formula 14, and as the base, potassium carbonate, sodium carbonate or a mixture thereof can be used, and various palladium complexes can be used as catalysts. Typically, tetrakis (triphenylphosphine) palladium (0) can be used.

상기 화학식 1a의 화합물의 제조에 사용되는 화학식 3의 화합물은 2번 탄소 위치에 -BOY1OY2 치환체를 갖는 나프탈렌 유도체이고; 상기 화학식 1b의 화합물의 제조에 사용되는 화학식 3의 화합물은 2번 탄소 위치에 -BOY1OY2 치환체를 갖고 1번 탄소 위치에 알킬기 또는 아릴기 치환체를 갖는 나프탈렌 유도체이고; 상기 화학식 1c의 화합물의 제조에 사용되는 화학식 3의 화합물은 1번 탄소 위치에 -BOY1OY2 치환체를 갖는 나프탈렌 유도체이고; 상기 화학식 1d의 화합물의 제조에 사용되는 화학식 3의 화합물은 2번 탄소 위치에 -BOY1OY2 치환체를 갖는 안트라센 유도체이고; 상기 화학식 1e의 화합물의 제조에 사용되는 화학식 3의 화합물은 2번 탄소 위치에 -BOY1OY2 치환체를 갖고 1번 탄소 위치에 알킬기 또는 아릴기 치환체를 갖는 안트라센 유도체이고; 상기 화학식 1f의 화합물의 제조에 사용되는 화학식 3의 화합물은 1번 탄소 위치에 -BOY1OY2 치환체를 갖는 안트라센 유도체이고; 상기 화학식 1g의 화합물의 제조에 사용되는 화학식 3의 화합물은 9번 탄소 위치에 -BOY1OY2 치환체를 갖는 페난트렌 유도체이고; 상기 화학식 1h의 화합물의 제조에 사용되는 화학식 3의 화합물은 1번 탄소 위치에 -BOY1OY2 치환체를 갖는 파이렌 유도체이다. The compound of formula 3 used to prepare the compound of formula 1a is a naphthalene derivative having a -BOY 1 OY 2 substituent at the carbon position 2 ; The compound of formula 3 used in the preparation of the compound of formula 1b is a naphthalene derivative having a -BOY 1 OY 2 substituent at the carbon position 2 and an alkyl or aryl substituent at the carbon position; The compound of formula 3 used in the preparation of the compound of formula 1c is a naphthalene derivative having a -BOY 1 OY 2 substituent at the carbon position 1 ; The compound of formula 3 used in the preparation of the compound of formula 1d is an anthracene derivative having a -BOY 1 OY 2 substituent at the carbon position 2 ; The compound of formula 3 used in the preparation of the compound of formula 1e is an anthracene derivative having a -BOY 1 OY 2 substituent at the carbon position 2 and an alkyl or aryl group substituent at the carbon position 1; The compound of formula 3 used to prepare the compound of formula 1f is an anthracene derivative having a -BOY 1 OY 2 substituent at position 1 carbon; The compound of formula 3 used to prepare the compound of formula 1g is a phenanthrene derivative having a -BOY 1 OY 2 substituent at the carbon position 9; The compound of formula 3 used in the preparation of the compound of formula 1h is a pyrene derivative having a -BOY 1 OY 2 substituent at the carbon position 1 .

또한, 본 발명은 상기 화학식 1의 화합물을 하나 이상의 유기층에 포함하 는 유기전기발광소자를 제공한다. 이때, 상기 유기층은 발광층을 필수적으로 포함하며, 발광층 외에도 정공주입층, 정공수송층, 전자주입층, 전자수송층 또는 이들의 적층체를 포함할 수 있다.In addition, the present invention provides an organic electroluminescent device comprising the compound of Formula 1 in at least one organic layer. In this case, the organic layer may essentially include a light emitting layer, and may include a hole injection layer, a hole transport layer, an electron injection layer, an electron transport layer, or a laminate thereof in addition to the light emitting layer.

본 발명의 유기전기발광소자는 양극, 음극, 및 상기 두 전극 사이에 적어도 하나의 발광층을 함유하는 단층 또는 다층으로 이루어진 유기층을 포함하며, 상기 유기층 중 1층 이상의 층이 상기 화학식 1의 신규 화합물을 함유한다. 예를 들어, 다층형 유기전기발광소자는 아래부터 기판, 양극, 정공주입층, 정공수송층, 발광층, 전자수송층, 전자주입층 및 음극의 다층 구조로 적층된다.The organic electroluminescent device of the present invention includes an anode, a cathode, and an organic layer consisting of a single layer or a multilayer containing at least one light emitting layer between the two electrodes, wherein at least one layer of the organic layer is a new compound of Formula 1 It contains. For example, the multilayer organic electroluminescent device is stacked in a multilayer structure of a substrate, an anode, a hole injection layer, a hole transport layer, a light emitting layer, an electron transport layer, an electron injection layer and a cathode from below.

즉, 화학식 1의 화합물은 도입하는 치환기의 종류에 따라 발광층 뿐만 아니라, 정공주입층, 정공수송층, 전자수송층 및 전자주입층 모두에 적용될 수 있다. 본 발명의 방향족 유도체는 열 증착 특성이 우수하고, 유기용매에 대한 용해도가 높아 습식 정제 수율이 높으며, 잉크젯 또는 스핀 코팅 등의 습식 성막도 가능한 장점을 갖는다.That is, the compound of Formula 1 may be applied to not only the light emitting layer but also the hole injection layer, the hole transport layer, the electron transport layer, and the electron injection layer, depending on the kind of the substituent to be introduced. The aromatic derivative of the present invention has excellent thermal evaporation characteristics, high solubility in organic solvents, high wet tablet yield, and wet film formation such as inkjet or spin coating.

본 발명에 따른 유기전기발광소자의 기판, 양극 및 음극은 통상적인 유기전기발광소자에 사용되는 물질로 이루어지며, 정공주입층, 정공수송층, 발광층, 전자수송층 및 전자주입층 각각은 화학식 1의 화합물, 통상적으로 사용되는 물질 또는 이들의 혼합물로 이루어질 수 있다.The substrate, the anode, and the cathode of the organic electroluminescent device according to the present invention are made of a material used in a conventional organic electroluminescent device, and the hole injection layer, the hole transport layer, the light emitting layer, the electron transport layer and the electron injection layer are each a compound of Formula 1 It may be made of a commonly used material or a mixture thereof.

특히, 발광층의 경우, 본 발명의 화학식 1의 화합물을 단독으로 또는 2가지 이상을 조합하여 사용하거나, 발광 호스트(host) 물질 또는 도판트(dopant) 물질로서 사용하여 공지된 다른 발광 도판트 물질 또는 호스트 물질과 함께 사용할 수 있다. 화학식 1의 화합물을 단독 발광물질 또는 호스트 물질로서 사용할 경우에는 발광층 대비 100 내지 50 중량%의 양으로 첨가할 수 있고, 도판트 물질로서 사용할 경우에는 발광층 대비 0.01 내지 50 중량%의 양으로 첨가할 수 있다. 화학식 1의 화합물과 함께 발광층에 사용할 수 있는 발광 물질(호스트 물질 또는 도판트 물질)의 구체적인 예로는 안트라센(anthracene) 유도체, 나프탈렌(naphthalene) 유도체, 페난트렌(phenanthrene) 유도체, 파이렌(pyrene) 유도체, 테트라센(tetracene) 유도체, 코로넨(coronene) 유도체, 크라이센(chrycene) 유도체, 플루오란텐(fluoranthene) 유도체, 페릴렌(perylene) 유도체, 프탈로페릴렌(phthaloperylene) 유도체, 스틸벤(stilibene) 유도체, 디스티릴아릴렌(distyrylarylene) 유도체, 페리논(perinone) 유도체, 프탈로페리논(phthaloperinone) 유도체, 나프탈로페리논(naphthaloperinone) 유도체, 다이페닐부타다이엔(diphenylbutadiene) 유도체, 테트라페닐부타다이엔(tetraphenylbutadiene) 유도체, 큐마린(coumarine) 유도체, 옥사다이아졸(oxadiazole) 유도체, 비스벤족사졸린(bisbenzoxazoline) 유도체, 비스스타이릴(bisstyryl) 유도체, 피라진(pyrazine) 유도체, 사이클로펜타다이엔(cyclopentadiene) 유도체, 퀴놀린(quinoline) 금속 착체 유도체, 아미노퀴놀린(aminoquinoline) 금속 착체 유도체, 벤조퀴놀린(benzoquinoline) 금속 착체 유도체, 이민(imine) 유도체, 다이페닐에틸렌(diphenylethylene) 유도체, 비닐안트라센(vinylanthracene) 유도체, 다이아미노카바졸(diaminocarbazole) 유도체, 피란(pyrane) 유도체, 티오피란(thiopyrane) 유도체, 퀴나크리돈(quinacridone) 유도 체, 루브렌(rubrene) 유도체, 기타 형광 색소 및 이들의 혼합물을 들 수 있지만, 이들에 한정되는 것은 아니다. 도판트 물질을 선택할 경우, 고효율의 형광 또는 인광을 가지면서 호스트 물질의 밴드갭(bandgap)보다 같거나 작은 밴드갭을 갖는 것이 바람직하다. In particular, in the case of the light emitting layer, other light emitting dopant materials known by using the compound of formula 1 of the present invention alone or in combination of two or more, or as a light emitting host material or a dopant material, or Can be used with host materials. When the compound of Formula 1 is used as a single light emitting material or a host material, it may be added in an amount of 100 to 50% by weight relative to the light emitting layer, and when used as a dopant material, it may be added in an amount of 0.01 to 50% by weight relative to the light emitting layer. have. Specific examples of the light emitting material (host material or dopant material) that can be used in the light emitting layer with the compound of Formula 1 include anthracene derivative, naphthalene derivative, phenanthrene derivative, pyrene derivative Tetrane derivatives, coronene derivatives, chrysene derivatives, fluoranthene derivatives, perylene derivatives, phthaloperylene derivatives, stilbenene ), Distyrylarylene derivatives, perinone derivatives, phthaloperinone derivatives, naphthaloperinone derivatives, diphenylbutadiene derivatives, tetraphenylbutadiene derivatives Tetraphenylbutadiene derivatives, coumarine derivatives, oxadiazole derivatives, bisbenzoxazoline derivatives, bisstyryl Conductors, pyrazine derivatives, cyclopentadiene derivatives, quinoline metal complex derivatives, aminoquinoline metal complex derivatives, benzoquinoline metal complex derivatives, imine derivatives, di Diphenylethylene Derivatives, Vinylanthracene Derivatives, Diaminocarbazole Derivatives, Pyrane Derivatives, Thiopyrane Derivatives, Quinacridone Derivatives, Rubrene Derivatives, other fluorescent dyes, and mixtures thereof, but are not limited thereto. When selecting a dopant material, it is desirable to have a high efficiency of fluorescence or phosphorescence and have a bandgap equal to or less than the bandgap of the host material.

유기전기발광소자를 구성하는 각각의 층은 진공 증착, 스퍼터링, 플라즈마, 이온 도금 등의 건식 성막법, 또는 방사 피복, 침지 피복, 유동 피복 등의 습식 성막법 중 임의의 통상적인 방법을 적용하여 형성시킬 수 있다. 막 두께는 특별히 한정되지 않으나, 막 두께가 너무 두꺼우면 일정한 광 출력을 얻기 위해 높은 인가전압이 필요하여 효율이 나빠지고, 막 두께가 너무 얇으면 핀홀(pin hole) 등이 발생하여 전기장을 인가하여도 충분한 발광 휘도가 얻어지지 않는다. 통상적인 막 두께는 5 nm 내지 10 ㎛의 범위가 바람직하나, 10 nm 내지 0.2 ㎛의 범위가 더욱 바람직하다.Each layer constituting the organic electroluminescent device is formed by applying any conventional method such as dry deposition method such as vacuum deposition, sputtering, plasma, ion plating, or wet deposition method such as radiation coating, immersion coating, and flow coating. You can. The film thickness is not particularly limited, but if the film thickness is too thick, a high applied voltage is required to obtain a constant light output, resulting in poor efficiency. If the film thickness is too thin, a pin hole or the like is generated to apply an electric field. Also, sufficient light emission luminance cannot be obtained. Typical film thickness is preferably in the range of 5 nm to 10 μm, but more preferably in the range of 10 nm to 0.2 μm.

이와 같이, 본 발명의 방향족 유도체는 우수한 내열성 및 박막 안정성을 가지므로, 이를 함유하는 유기전기발광소자는 현저히 향상된 구동전압, 발광효율, 색순도 및 수명 특성을 나타낸다.Thus, since the aromatic derivative of the present invention has excellent heat resistance and thin film stability, the organic electroluminescent device containing the same exhibits significantly improved driving voltage, luminous efficiency, color purity and lifespan characteristics.

이하 본 발명을 하기 실시예에 의거하여 좀 더 상세하게 설명하고자 한다. 단, 하기 실시예는 본 발명을 예시하기 위한 것일 뿐 한정하지는 않는다.Hereinafter, the present invention will be described in more detail based on the following examples. However, the following examples are not intended to limit the invention only.

[실시예]EXAMPLE

<화합물의 합성>Synthesis of Compound

실시예 1 : 본 발명의 화합물 1, 59, 60, 208, 255, 302의 합성 (하기 반응식 5 참조)Example 1 Synthesis of Compounds 1, 59, 60, 208, 255, 302 of the Invention (See Scheme 5 below)

Figure 112009059119266-PAT00024
Figure 112009059119266-PAT00024

1-1) 중간체 1의 합성 1-1) Synthesis of Intermediate 1

250 ml 3구 둥근바닥플라스크에 1,8-다이브로모나프탈렌(6 g), 2-나프탈렌보론산(4 g), 테트라하이드로퓨란(120 ml), 탄산칼륨(6.5 g) 및 물(50 ml)을 넣고 교반하였다. 이 혼합액에 테트라키스(트리페닐포스핀)팔라듐(0) (1.3 g)을 넣고 80℃로 가열하였다. 반응액을 층 분리하여 물을 제거하고 유기층을 물로 2 회 세척하였다. 유기층을 황산마그네슘으로 건조한 후 감압 농축하여 용매를 제거하였다. 농축에 의해 생성된 물질을 헥산을 이용하여 컬럼 분리하여 표제 화합물 5.5 g을 얻었다.In a 250 ml three-necked round bottom flask, 1,8-dibromonaphthalene (6 g), 2-naphthalene boronic acid (4 g), tetrahydrofuran (120 ml), potassium carbonate (6.5 g) and water (50 ml) Was added and stirred. Tetrakis (triphenylphosphine) palladium (0) (1.3 g) was added to this mixed solution, and it heated to 80 degreeC. The reaction solution was separated into layers to remove water, and the organic layer was washed twice with water. The organic layer was dried over magnesium sulfate and concentrated under reduced pressure to remove the solvent. The material produced by concentration was separated by column using hexane to give 5.5 g of the title compound.

1-2) 중간체 2의 합성1-2) Synthesis of Intermediate 2

250 ml 3구 둥근바닥플라스크에 1,8-다이브로모나프탈렌(10 g), 페난트렌-9-일 보론산(8.5 g), 테트라하이드로퓨란(100 ml), 탄산칼륨(10.6 g) 및 물(50 ml)을 넣고 교반하였다. 이 혼합액에 테트라키스(트리페닐포스핀)팔라듐(0) (2.2 g)을 넣고 80℃로 가열하였다. 반응액을 층분리하여 물을 제거하고 유기층을 물로 2 회 세척하였다. 유기층을 황산마그네슘으로 건조한 후 감압 농축하여 용매를 제거하였다. 농축에 의해 생성된 물질을 헥산을 이용하여 컬럼 분리하여 표제 화합물 10.5 g을 얻었다.In a 250 ml three-neck round bottom flask, 1,8-dibromonaphthalene (10 g), phenanthrene-9-yl boronic acid (8.5 g), tetrahydrofuran (100 ml), potassium carbonate (10.6 g) and water ( 50 ml) was added and stirred. Tetrakis (triphenylphosphine) palladium (0) (2.2 g) was added to this mixed solution, and it heated to 80 degreeC. The reaction solution was separated and the water was removed, and the organic layer was washed twice with water. The organic layer was dried over magnesium sulfate and concentrated under reduced pressure to remove the solvent. The material produced by concentration was separated by column using hexane to give 10.5 g of the title compound.

1-3) 중간체 3의 합성1-3) Synthesis of Intermediate 3

2000 ml 3구 둥근바닥플라스크에 1,8-다이브로모나프탈렌(58 g), 6-페닐나프탈렌-2-일 보론산(50 g), 테트라하이드로퓨란(500 ml), 탄산칼륨(42 g) 및 물(250 ml)을 넣고 교반하였다. 이 혼합액에 테트라키스(트리페닐포스핀)팔라듐(0) (11.7 g)을 넣고 80℃로 가열하였다. 반응액을 층분리하여 물을 제거하고 유기층을 물로 2 회 세척하였다. 유기층을 황산마그네슘으로 건조한 후 감압 농축하여 용매를 제거하였다. 농축에 의해 생성된 물질을 헥산을 이용하여 컬럼 분리하여 표제 화합물 50 g을 얻었다.In a 2000 ml three-necked round bottom flask, 1,8-dibromonaphthalene (58 g), 6-phenylnaphthalen-2-yl boronic acid (50 g), tetrahydrofuran (500 ml), potassium carbonate (42 g) and Water (250 ml) was added and stirred. Tetrakis (triphenylphosphine) palladium (0) (11.7 g) was added to this mixed solution and heated to 80 占 폚. The reaction solution was separated and the water was removed, and the organic layer was washed twice with water. The organic layer was dried over magnesium sulfate and concentrated under reduced pressure to remove the solvent. The material produced by concentration was separated by column using hexane to give 50 g of the title compound.

1-4) 중간체 4의 합성1-4) Synthesis of Intermediate 4

2000 ml 3구 둥근바닥플라스크에 1,8-다이브로모나프탈렌(58 g), 2,2'-바이나프틸-6-일 보론산(60 g), 테트라하이드로퓨란(500 ml), 탄산칼륨(42 g) 및 물(250 ml)을 넣고 교반하였다. 이 혼합액에 테트라키스(트리페닐포스핀)팔라듐(0) (11.7 g)을 넣고 80℃로 가열하였다. 반응액을 층분리하여 물을 제거하고 유기층을 물로 2 회 세척하였다. 유기층을 황산마그네슘으로 건조한 후 감압 농축하여 용매를 제거하였다. 농축에 의해 생성된 물질을 헥산을 이용하여 컬럼 분리하여 표제 화합물 71 g을 얻었다.In a 2000 ml three-necked round bottom flask, 1,8-dibromonaphthalene (58 g), 2,2'-binaphthyl-6-yl boronic acid (60 g), tetrahydrofuran (500 ml), potassium carbonate ( 42 g) and water (250 ml) were added and stirred. Tetrakis (triphenylphosphine) palladium (0) (11.7 g) was added to this mixed solution and heated to 80 占 폚. The reaction solution was separated and the water was removed, and the organic layer was washed twice with water. The organic layer was dried over magnesium sulfate and concentrated under reduced pressure to remove the solvent. The material produced by concentration was separated by column using hexane to give 71 g of the title compound.

1-5) 중간체 5의 합성1-5) Synthesis of Intermediate 5

100 ml 3구 둥근바닥플라스크에 중간체 1(5.5 g) 및 테트라하이드로퓨란(40 ml)을 넣은 후 아르곤 분위기 하에서 교반하고 혼합액의 온도를 -78℃로 낮추어 주었다. 여기에 n-뷰틸리튬(12 ml)를 천천히 첨가한 후 2시간 동안 교반하였다. 플루오레논(3 g)을 테트라하이드로퓨란(12 ml)에 녹인 용액을 상기 혼합액에 천천히 투 입하고 혼합액의 온도를 상온으로 승온한 후 12 시간 동안 교반하였다. 반응액에 물(20 ml)을 넣고 2 시간 동안 교반하였다. 반응액을 층분리하여 물을 제거하고 유기층을 냉각한 후 결정을 여과하여 표제 화합물 3.8 g을 얻었다.Intermediate 1 (5.5 g) and tetrahydrofuran (40 ml) were added to a 100 ml three-necked round bottom flask, and the mixture was stirred under an argon atmosphere and the temperature of the mixed solution was lowered to -78 ° C. N -butyllithium (12 ml) was slowly added thereto, followed by stirring for 2 hours. A solution of fluorenone (3 g) dissolved in tetrahydrofuran (12 ml) was slowly added to the mixture, and the temperature of the mixture was raised to room temperature, followed by stirring for 12 hours. Water (20 ml) was added to the reaction solution and stirred for 2 hours. The reaction solution was separated and the water was removed, the organic layer was cooled, and the crystals were filtered to yield 3.8 g of the title compound.

1-6) 중간체 6의 합성1-6) Synthesis of Intermediate 6

250ml 3구 둥근바닥플라스크에 중간체 2(10.5 g) 및 테트라하이드로퓨란(80 ml)를 넣은 후 아르곤 분위기 하에서 교반하고 혼합액의 온도를 -78℃로 낮추어 주었다. 여기에 n-뷰틸리튬(20 ml)를 천천히 첨가한 후 2시간 동안 교반하였다. 플루오레논(4.9 g)을 테트라하이드로퓨란(20 ml)에 녹인 용액을 상기 혼합액에 천천히 투입하고 혼합액의 온도를 상온으로 승온한 후 12시간 동안 교반하였다. 반응액에 물(50 ml)을 넣고 2 시간 동안 교반하였다. 반응액을 층분리하여 물을 제거하고 유기층을 냉각한 후 결정을 여과하여 표제 화합물 9.7 g을 얻었다.Intermediate 2 (10.5 g) and tetrahydrofuran (80 ml) were added to a 250 ml three-necked round bottom flask, and the mixture was stirred under an argon atmosphere and the temperature of the mixed solution was lowered to -78 ° C. N -butyllithium (20 ml) was slowly added thereto, followed by stirring for 2 hours. A solution of fluorenone (4.9 g) dissolved in tetrahydrofuran (20 ml) was slowly added to the mixed solution, and the temperature of the mixed solution was raised to room temperature, followed by stirring for 12 hours. Water (50 ml) was added to the reaction solution and stirred for 2 hours. The reaction solution was separated and the water was removed, the organic layer was cooled, and the crystals were filtered to obtain 9.7 g of the title compound.

1-7) 중간체 7의 합성1-7) Synthesis of Intermediate 7

2000 ml 3구 둥근바닥플라스크에 중간체 3(35 g) 및 테트라하이드로퓨란(550 ml)를 넣은 후 아르곤 분위기 하에서 교반하고 혼합액의 온도를 -78℃로 낮추어 주었다. 여기에 n-뷰틸리튬 (60 ml)를 천천히 첨가한 후 2시간 동안 교반하였다. 플루오레논(17 g)을 테트라하이드로퓨란(65 ml)에 녹인 용액을 상기 혼합액에 천천히 투입하고 혼합액의 온도를 상온으로 승온한 후 12 시간 동안 교반하였다. 반응액에 물(500 ml)을 넣고 2 시간 동안 교반하였다. 반응액을 층분리하여 물을 제거하고 유기층을 냉각한 후 결정을 여과하여 표제 화합물 43 g을 얻었다.Intermediate 3 (35 g) and tetrahydrofuran (550 ml) were added to a 2000 ml three-neck round bottom flask, and the mixture was stirred under an argon atmosphere and the temperature of the mixed solution was lowered to -78 ° C. N -butyllithium (60 ml) was slowly added thereto and stirred for 2 hours. A solution of fluorenone (17 g) dissolved in tetrahydrofuran (65 ml) was slowly added to the mixed solution, and the temperature of the mixed solution was raised to room temperature, followed by stirring for 12 hours. Water (500 ml) was added to the reaction solution and stirred for 2 hours. The reaction solution was separated and the water was removed, the organic layer was cooled, and the crystals were filtered to obtain 43 g of the title compound.

1-8) 중간체 8의 합성1-8) Synthesis of Intermediate 8

100 ml 3구 둥근바닥플라스크에 중간체 3 6.5g 및 테트라하이드로퓨란 45ml를 넣은 후 아르곤 분위기 하에서 교반하고 혼합액의 온도를 -78℃로 낮추어 주었다. 여기에 n-뷰틸리튬(11 ml)를 천천히 첨가한 후 2시간 동안 교반하였다. 2,7-다이-t-뷰틸 플루오레논(3.0 g)을 테트라하이드로퓨란(12 ml)에 녹인 용액을 상기 혼합액에 천천히 투입하고 혼합액의 온도를 상온으로 승온한 후 12 시간 동안 교반하였다. 반응액에 물(70 ml)을 넣고 2 시간 동안 교반하였다. 반응액을 층분리하여 물을 제거하고 유기층을 냉각한 후 결정을 여과하여 표제 화합물 3.5 g을 얻었다.6.5 g of intermediate 3 and 45 ml of tetrahydrofuran were added to a 100 ml three-necked round bottom flask, and the mixture was stirred under an argon atmosphere and the temperature of the mixed solution was lowered to -78 ° C. N -butyllithium (11 ml) was slowly added thereto, followed by stirring for 2 hours. A solution of 2,7-di- t -butyl fluorenone (3.0 g) dissolved in tetrahydrofuran (12 ml) was slowly added to the mixed solution, and the temperature of the mixed solution was raised to room temperature, followed by stirring for 12 hours. Water (70 ml) was added to the reaction solution and stirred for 2 hours. The reaction solution was separated and the water was removed, the organic layer was cooled, and the crystals were filtered to obtain 3.5 g of the title compound.

1-9) 중간체 9의 합성1-9) Synthesis of Intermediate 9

100 ml 3구 둥근바닥플라스크에 중간체 3(6.5 g) 및 테트라하이드로퓨란(45 ml)를 넣은 후 아르곤 분위기 하에서 교반하고 혼합액의 온도를 -78℃로 낮추어 주었다. 여기에 n-뷰틸리튬(11 ml)를 천천히 첨가한 후 2시간 동안 교반하였다. 벤조페논(3.0 g)을 테트라하이드로퓨란(12 ml)에 녹인 용액을 상기 혼합액에 천천히 투입하고 혼합액의 온도를 상온으로 승온한 후 12시간 동안 교반하였다. 반응액에 물(70 ml)을 넣고 2시간 동안 교반하였다. 반응액을 층분리하여 물을 제거하고 유기층을 냉각한 후 결정을 여과하여 표제 화합물 3.9 g을 얻었다.Intermediate 3 (6.5 g) and tetrahydrofuran (45 ml) were added to a 100 ml three-necked round bottom flask, and the mixture was stirred under an argon atmosphere and the temperature of the mixed solution was lowered to -78 ° C. N -butyllithium (11 ml) was slowly added thereto, followed by stirring for 2 hours. A solution of benzophenone (3.0 g) dissolved in tetrahydrofuran (12 ml) was slowly added to the mixed solution, and the temperature of the mixed solution was raised to room temperature, followed by stirring for 12 hours. Water (70 ml) was added to the reaction solution and stirred for 2 hours. The reaction solution was separated and the water was removed, the organic layer was cooled and the crystals were filtered to yield 3.9 g of the title compound.

1-10) 중간체 10 의 합성1-10) Synthesis of Intermediate 10

2000 ml 3구 둥근바닥플라스크에 중간체 4(71 g) 및 테트라하이드로퓨란(700 ml)를 넣은 후 아르곤 분위기 하에서 교반하고 혼합액의 온도를 -78℃로 낮추어 주었다. 여기에 n-뷰틸리튬 (107 ml)를 천천히 첨가한 후 2시간 동안 교반하였다. 플루오레논(28 g)을 테트라하이드로퓨란(120 ml)에 녹인 용액을 상기 혼합액에 천천히 투입하고 혼합액의 온도를 상온으로 승온한 후 12 시간 동안 교반하였다. 반응액에 물(710 ml)을 넣고 2 시간 동안 교반하였다. 반응액을 층분리하여 물을 제거하고 유기층을 냉각한 후 결정을 여과하여 표제 화합물 86 g을 얻었다.Intermediate 4 (71 g) and tetrahydrofuran (700 ml) were added to a 2000 ml three-necked round bottom flask, and the mixture was stirred under an argon atmosphere and the temperature of the mixed solution was lowered to -78 ° C. N -butyllithium (107 ml) was slowly added thereto and stirred for 2 hours. A solution of fluorenone (28 g) dissolved in tetrahydrofuran (120 ml) was slowly added to the mixed solution, and the temperature of the mixed solution was raised to room temperature, followed by stirring for 12 hours. Water (710 ml) was added to the reaction solution and stirred for 2 hours. The reaction solution was separated and the water was removed, the organic layer was cooled, and the crystals were filtered to give 86 g of the title compound.

1-11) 화합물 1의 합성1-11) Synthesis of Compound 1

100 ml 3구 둥근바닥플라스크에 중간체 5(3.8 g), 아세트산(70 ml) 및 염산(4 ml)을 첨가한 후 110℃에서 8 시간 동안 교반한 다음 냉각하였다. 반응액을 여과하고 물 및 메탄올로 순차적으로 씻어준 다음 건조하여 흰색 분말의 표제 화합물 3.6 g을 얻었다.Intermediate 5 (3.8 g), acetic acid (70 ml) and hydrochloric acid (4 ml) were added to a 100 ml three-necked round bottom flask, which was then stirred at 110 ° C. for 8 hours and then cooled. The reaction solution was filtered, washed sequentially with water and methanol, and dried to obtain 3.6 g of the title compound as a white powder.

1H-NMR(CDCl3, 500MHz) (1H, d, 8.42775, 8.40987), (1H, d, 8.316, 8.301), (2H, d, 7.98059, 7.96553), (1H, d, 7.89538, 7.87761), (1H, d, 7.80064, 7.78440), (1H, d, 7.68838, 7.67250), (1H, t, 7.62878∼7.59755), (1H, d, 7.58013, 7.56439), (2H, t, 7.38501∼7.35506), (2H, m, 7.17714∼7.10432), (3H, m, 7.07895∼7.03997), (2H, d, 6.94997, 6.93483), (1H, t, 6.82012∼6.78612), (1H, d, 6.55999, 6.54491) 1 H-NMR (CDCl 3 , 500 MHz) (1H, d, 8.42775, 8.40987), (1H, d, 8.316, 8.301), (2H, d, 7.98059, 7.96553), (1H, d, 7.89538, 7.87761), (1H, d, 7.80064, 7.78440), (1H, d, 7.68838, 7.67250), (1H, t, 7.62878-7.59755), (1H, d, 7.58013, 7.56439), (2H, t, 7.38501-7.35506), (2H, m, 7.17714-7.10432), (3H, m, 7.07895-7.03997), (2H, d, 6.94997, 6.93483), (1H, t, 6.82012-6.78612), (1H, d, 6.55999, 6.54491)

EI-MS : m/z 416(M+)EI-MS: m / z 416 (M +)

1-12) 화합물 302의 합성1-12) Synthesis of Compound 302

250 ml 3구 둥근바닥플라스크에 중간체 6(9.7 g), 아세트산(200 ml) 및 염산(8 ml)을 첨가한 후 110℃에서 8 시간 동안 교반한 다음 냉각하였다. 반응액을 여과하고 물 및 메탄올로 순차적으로 씻어준 다음 건조하여 흰색 분말의 표제 화합물 9.1 g을 얻었다.Intermediate 6 (9.7 g), acetic acid (200 ml) and hydrochloric acid (8 ml) were added to a 250 ml three-neck round bottom flask, followed by stirring at 110 ° C. for 8 hours and then cooling. The reaction solution was filtered, washed sequentially with water and methanol and dried to obtain 9.1 g of the title compound as a white powder.

1H-NMR(CDCl3, 500MHz) (2H, d, 8.93082, 8.89066), (1H, d, 8.41952, 8.40354), (2H, d, 8.12165, 8.10496), (1H, d, 8.01093, 8.00163), (6H, m, 7.92376∼7.87063), (3H, m, 7.58264∼7.55027), (4H, m, 7.42365∼7.38121), (2H, t, 7.31384∼7.28132), (1H, d, 7.00163∼6.98575) 1 H-NMR (CDCl 3 , 500 MHz) (2H, d, 8.93082, 8.89066), (1H, d, 8.41952, 8.40354), (2H, d, 8.12165, 8.10496), (1H, d, 8.01093, 8.00163), (6H, m, 7.92376-7.87063), (3H, m, 7.58264-7.55027), (4H, m, 7.42365-7.8121), (2H, t, 7.31384-7.8132), (1H, d, 7.00163-6.98575)

EI-MS : m/z 467(M+)EI-MS: m / z 467 (M +)

1-13) 화합물 59의 합성1-13) Synthesis of Compound 59

100 ml 3구 둥근바닥플라스크에 중간체 7(43 g), 아세트산(800 ml) 및 염산(40 ml)을 첨가한 후 110℃에서 8 시간 동안 교반한 다음 냉각하였다. 반응액을 여과하고 물 및 메탄올로 순차적으로 씻어준 다음 건조하여 흰색 분말의 표제 화합물 40 g을 얻었다.Intermediate 7 (43 g), acetic acid (800 ml) and hydrochloric acid (40 ml) were added to a 100 ml three-necked round bottom flask, which was then stirred at 110 ° C. for 8 hours and then cooled. The reaction solution was filtered, washed sequentially with water and methanol, and dried to obtain 40 g of the title compound as a white powder.

1H-NMR(CDCl3, 500MHz) (1H, d, 8.45317∼8.43528), (1H, d, 8.32603, 8.31116), (2H, d, 7.99765, 7.98240), (1H, d, 7.95173∼7.93396), (1H, s, 7.88883), (1H, d, 7.80715, 7.79085), (1H, t, 7.63564∼7.60448), (1H, d, 7.58855, 7.57266), (2H, d, 7.54821, 7.53275), (2H, d, 7.39860, 7.38346), (2H, d, 7.36412, 7.34842), (1H, d, 7.29392∼7.27912), (5H, m, 7.15040∼7.05950), (2H, d, 6.98521, 6.97011), (1H, d, 6.57606∼6.56095) 1 H-NMR (CDCl 3 , 500 MHz) (1H, d, 8.45317-8.43528), (1H, d, 8.32603, 8.31116), (2H, d, 7.99765, 7.98240), (1H, d, 7.95173-7.93396), (1H, s, 7.88883), (1H, d, 7.80715, 7.79085), (1H, t, 7.63564-77.60448), (1H, d, 7.58855, 7.57266), (2H, d, 7.54821, 7.53275), (2H , d, 7.39860, 7.38346), (2H, d, 7.36412, 7.34842), (1H, d, 7.29392-7.27912), (5H, m, 7.15040-7.05950), (2H, d, 6.98521, 6.97011), (1H , d, 6.57606-6.56095)

EI-MS : m/z 492(M+)EI-MS: m / z 492 (M +)

1-14) 화합물 255의 합성1-14) Synthesis of Compound 255

100 ml 3구 둥근바닥플라스크에 중간체 8(3.5 g), 아세트산(80 ml) 및 염산(4 ml)을 첨가한 후 110℃에서 8 시간 동안 교반한 다음 냉각하였다. 반응액을 여과하고 물 및 메탄올로 순차적으로 씻어준 다음 건조하여 흰색 분말의 표제 화합물 2.5 g을 얻었다.Intermediate 8 (3.5 g), acetic acid (80 ml) and hydrochloric acid (4 ml) were added to a 100 ml three-necked round bottom flask, followed by stirring at 110 ° C. for 8 hours and then cooling. The reaction solution was filtered, washed sequentially with water and methanol, and dried to obtain 2.5 g of the title compound as a white powder.

1H-NMR(CDCl3, 500MHz) 1H(d, 8.46103~8.44316), 1H(d, 8.34260~8.32779), 1H(d, 7.95108~7.93330), 1H(s, 7.89272), 2H(d, 7.84917~7.83304), 1H(d, 7.81230~7.79609), 1H(t, 7.64684~7.61571), 3H(d, 7.58065~7.56486), 4H(m, 7.39828~7.35988), 1H(d, 7.29775~7.28321), 3H(m, 7.13826~7.08150), 2H(s, 6.91532), 1H(d, 6.58715~6.57213), 18H(s, 1.02374) 1 H-NMR (CDCl 3 , 500MHz) 1H (d, 8.46103 ~ 8.44316), 1H (d, 8.34260 ~ 8.32779), 1H (d, 7.95108 ~ 7.93330), 1H (s, 7.89272), 2H (d, 7.84917 ~ 7.83304), 1H (d, 7.81230 ~ 7.79609), 1H (t, 7.64684 ~ 7.61571), 3H (d, 7.58065 ~ 7.56486), 4H (m, 7.39828 ~ 7.35988), 1H (d, 7.29775 ~ 7.28321), 3H ( m, 7.13826-7.08150), 2H (s, 6.91532), 1H (d, 6.58715-6.57213), 18H (s, 1.02374)

EI-MS : m/z 604(M+)EI-MS: m / z 604 (M +)

1-15) 화합물 208의 합성1-15) Synthesis of Compound 208

100 ml 3구 둥근바닥플라스크에 중간체 9(3.9 g), 아세트산(80 ml) 및 염산(4 ml)을 첨가한 후 110℃에서 8 시간 동안 교반한 다음 냉각하였다. 반응액을 여과하고 물 및 메탄올로 순차적으로 씻어준 다음 건조하여 흰색 분말의 표제 화합물 3.5 g을 얻었다.Intermediate 9 (3.9 g), acetic acid (80 ml) and hydrochloric acid (4 ml) were added to a 100 ml three-necked round bottom flask, followed by stirring at 110 ° C. for 8 hours and then cooling. The reaction solution was filtered, washed sequentially with water and methanol, and dried to obtain 3.5 g of the title compound as a white powder.

1H-NMR(CDCl3, 500MHz) 1H(d, 8.27492~8.25722), 1H(d, 8.12335~8.10880), 2H(d, 7.98997~7.97181), 1H(d, 7.79700~7.78094), 2H(d, 7.68960~7.67000), 2H(d, 7.65107~7.64882), 1H(t, 7.56945~7.53826), 3H(m, 7.43582~ 7.37401), 5H(m, 7.33843~7.31328), 1H(d, 7.24848~7.22573), 7H(m, 7.17432~7.08918) 1 H-NMR (CDCl 3 , 500 MHz) 1H (d, 8.27492-8.25722), 1H (d, 8.12335-8.10880), 2H (d, 7.98997-7.97181), 1H (d, 7.79700-7.8094), 2H (d, 7.68960 ~ 7.67000), 2H (d, 7.65107 ~ 7.64882), 1H (t, 7.56945 ~ 7.53826), 3H (m, 7.43582 ~ 7.37401), 5H (m, 7.33843 ~ 7.31328), 1H (d, 7.24848 ~ 7.22573), 7H (m, 7.17432-7.08918)

EI-MS : m/z 494(M+)EI-MS: m / z 494 (M +)

1-16) 화합물 60의 합성1-16) Synthesis of Compound 60

2000 ml 3구 둥근바닥플라스크에 중간체 10(86 g), 아세트산(860 ml) 및 염산(65 ml)을 첨가한 후 110℃에서 8 시간 동안 교반한 다음 냉각하였다. 반응액을 여과하고 물 및 메탄올로 순차적으로 씻어준 다음 건조하여 흰색 분말의 표제 화합물 73 g을 얻었다.Intermediate 10 (86 g), acetic acid (860 ml) and hydrochloric acid (65 ml) were added to a 2000 ml three-necked round bottom flask, which was then stirred at 110 ° C. for 8 hours and then cooled. The reaction solution was filtered, washed sequentially with water and methanol and dried to give 73 g of the title compound as a white powder.

1H-NMR(CDCl3, 500MHz) 1H(d, 8.47328~8.45531), 1H(8.33741~8.32272), 5H(m, 8.02071~7.97134), 4H(m, 7.84917~7.79753), 1H(d, 7.72216~7.71878), 1H(t, 7.64235~7.60942), 1H(d, 7.59455~7.57882), 2H(m, 7.46937~7.27417), 2H(t, 7.41111~7.37974), 1H(d,7.24121~7.22491), 1H(d, 7.19883~7.18285) 1H(t, 7.15221~7.11999), 2H(t, 7.10141~7.07155), 2H(d, 7.00241~6.98724), 1H(d, 6.58911~6.57411) 1 H-NMR (CDCl 3 , 500 MHz) 1H (d, 8.47328-8.45531), 1H (8.33741-8.32272), 5H (m, 8.02071-7.97134), 4H (m, 7.84917-7.79753), 1H (d, 7.72216- 7.71878), 1H (t, 7.64235 ~ 7.60942), 1H (d, 7.59455 ~ 7.57882), 2H (m, 7.46937 ~ 7.27417), 2H (t, 7.41111 ~ 7.37974), 1H (d, 7.24121 ~ 7.22491), 1H ( d, 7.19883 ~ 7.18285) 1H (t, 7.15221 ~ 7.11999), 2H (t, 7.10141 ~ 7.07155), 2H (d, 7.00241 ~ 6.98724), 1H (d, 6.58911 ~ 6.57411)

EI-MS : m/z 543(M+)EI-MS: m / z 543 (M +)

실시예 2 : 본 발명의 화합물 30, 35의 합성 (하기 반응식 6 참조)Example 2 Synthesis of Compounds 30 and 35 of the Invention (See Scheme 6 below)

Figure 112009059119266-PAT00025
Figure 112009059119266-PAT00025

2-1) 중간체 11의 합성2-1) Synthesis of Intermediate 11

500ml 둥근바닥플라스크에 화합물 1(3.6 g) 및 사염화탄소(350 ml)를 넣고 상온에서 브롬(1.4 ml)을 천천히 첨가하고 12시간 동안 교반하였다. 이 반응액에 탄산수소나트륨 수용액을 첨가하고 1시간 동안 교반한 후 층분리하여 물을 제거하 고, 유기층을 물로 2 회 더 씻어준 후 용매를 감압 농축 제거하여 표제 화합물 3.5g을 얻었다.Compound 1 (3.6 g) and carbon tetrachloride (350 ml) were added to a 500 ml round bottom flask, and bromine (1.4 ml) was slowly added at room temperature, followed by stirring for 12 hours. An aqueous sodium hydrogen carbonate solution was added to the reaction solution, the mixture was stirred for 1 hour, and the layers were separated to remove water. The organic layer was washed twice with water, and then the solvent was concentrated under reduced pressure to obtain 3.5 g of the title compound.

2-2) 화합물 30의 합성2-2) Synthesis of Compound 30

100ml 3구 둥근바닥플라스크에 중간체 11(2.5 g), 페난트렌-9-보론산(1.2 g), 테트라하이드로퓨란(30 ml), 탄산칼륨(1.2 g) 및 물(12 ml)을 넣고 교반하였다. 이 혼합액에 테트라키스(트리페닐포스핀)팔라듐(0)(0.31 g)을 넣고 80℃로 가열하였다. 반응액을 냉각한 후 여과하고 결정을 아세톤으로 씻어준 후 염화메틸렌으로 재결정하여 표제 화합물 2.8g을 얻었다.In a 100 ml three-necked round bottom flask, intermediate 11 (2.5 g), phenanthrene-9-boronic acid (1.2 g), tetrahydrofuran (30 ml), potassium carbonate (1.2 g) and water (12 ml) were added and stirred. . Tetrakis (triphenylphosphine) palladium (0) (0.31 g) was added to this mixed solution, and it heated to 80 degreeC. The reaction solution was cooled, filtered and the crystals were washed with acetone and recrystallized with methylene chloride to obtain 2.8 g of the title compound.

1H-NMR(CDCl3, 500MHz) (2H, t, 8.80632∼8.76906), (1H, d, 8.51897, 8.50110), (1H, d, 8.45247, 8.43721), (3H, m, 7.99857∼7.93160), (1H, d, 7.90403, 7.88842), (1H, s, 7.82223), (3H, t, 7.72569∼7.69858), (2H, m, 7.66060∼7.62945), (1H, d, 7.58735, 7.57104), (2H, t, 7.43138∼7.39448), (1H, t, 7.38109∼7.34908), (2H, m, 7.23078∼7.17798), (4H, m, 7.15621∼7.09810), (1H, d, 7.08400, 7.07189), (1H, t, 6.93138∼6.89953), (1H, t, 6.85192∼6.81964), (1H, d, 6.57207, 6.55711) 1 H-NMR (CDCl 3 , 500 MHz) (2H, t, 8.80632-8.76906), (1H, d, 8.51897, 8.50110), (1H, d, 8.45247, 8.43721), (3H, m, 7.99857-7.73160), (1H, d, 7.90403, 7.88842), (1H, s, 7.82223), (3H, t, 7.72569-77.65858), (2H, m, 7.66060-77.64545), (1H, d, 7.58735, 7.57104), (2H , t, 7.43138-7.39448), (1H, t, 7.38109-7.34908), (2H, m, 7.23078-7.17798), (4H, m, 7.15621-7.09810), (1H, d, 7.08400, 7.07189), (1H , t, 6.93138 to 6.89953), (1H, t, 6.85192 to 6.81964), (1H, d, 6.57207, 6.55711)

EI-MS : m/z 592(M+)EI-MS: m / z 592 (M +)

2-3) 화합물 35의 합성 2-3) Synthesis of Compound 35

100ml 3구 둥근바닥플라스크에 중간체 11(4 g), 4-(1-나프탈렌)-1-페닐보론산(2.3 g), 테트라하이드로퓨란(40 ml), 탄산칼륨(2.5 g) 및 물(20 ml)을 넣고 교반하였다. 이 혼합액에 테트라키스(트리페닐포스핀)팔라듐(0)(0.53 g)을 넣고 80℃로 가열하였다. 반응액을 냉각한 후 여과하고 결정을 아세톤으로 씻어준 후 염화메틸렌으로 재결정하여 표제 화합물 2g을 얻었다.In a 100 ml three-necked round bottom flask, intermediate 11 (4 g), 4- (1-naphthalene) -1-phenylboronic acid (2.3 g), tetrahydrofuran (40 ml), potassium carbonate (2.5 g) and water (20 ml) was added and stirred. Tetrakis (triphenylphosphine) palladium (0) (0.53 g) was added to this mixed solution, and it heated at 80 degreeC. The reaction solution was cooled, filtered and the crystals were washed with acetone and recrystallized with methylene chloride to obtain 2 g of the title compound.

1H-NMR(CDCl3, 500MHz) (1H, d, 8.48532, 8.46735), (1H, d, 8.41562, 8.40007), (1H, d, 8.07572, 8.05957), (2H, d, 7.99909, 7.98380), (3H, m, 7.94149∼7.88387), (1H, d, 7.83335, 7.81698), (6H, m, 7.71184∼7.61582), (4H, m, 7.56625∼7.48845), (2H, t, 7.4.551∼7.37579), (1H, t, 7.19805∼7.16625), (1H, t, 7.15543∼7.12234), (3H, t, 7.10562~7.07492), (2H, d, 7.02127∼7.00615), (1H, t, 6.84303∼6.81196), (1H, d, 6.62948, 6.61470) 1 H-NMR (CDCl 3 , 500 MHz) (1H, d, 8.48532, 8.46735), (1H, d, 8.41562, 8.40007), (1H, d, 8.07572, 8.05957), (2H, d, 7.99909, 7.98380), (3H, m, 7.94149-7.88387), (1H, d, 7.83335, 7.81698), (6H, m, 7.71184-7.61582), (4H, m, 7.56625-7.48845), (2H, t, 7.4.551-7.7579 ), (1H, t, 7.19805 to 7.16625), (1H, t, 7.15543 to 7.72234), (3H, t, 7.10562 to 7.07492), (2H, d, 7.02127 to 7.00615), (1H, t, 6.84303 to 6.71196 ), (1H, d, 6.62948, 6.61470)

EI-MS : m/z 618(M+)EI-MS: m / z 618 (M +)

실시예 3 : 본 발명의 화합물 94, 105, 106, 107, 110, 112의 합성 (하기 반응식 7 참조)Example 3 Synthesis of Compounds 94, 105, 106, 107, 110, 112 of the Invention (See Scheme 7 below)

Figure 112009059119266-PAT00026
Figure 112009059119266-PAT00026

3-1) 중간체 12의 합성3-1) Synthesis of Intermediate 12

10 L 3구 반응조에 화합물 59(40 g) 및 사염화탄소(4000 ml)를 넣고 상온에서 브롬(14 ml)를 천천히 첨가하고 12시간 동안 교반하였다. 이 반응액에 탄산수소나트륨 수용액을 첨가하고 1시간 동안 교반한 후 층분리하여 물을 제거하고, 유기 층을 물로 2 회 더 씻어준 후 용매를 감압 농축 제거하여 표제 화합물 36 g을 얻었다.Compound 59 (40 g) and carbon tetrachloride (4000 ml) were added to a 10 L three-neck reactor, and bromine (14 ml) was slowly added at room temperature, followed by stirring for 12 hours. An aqueous sodium hydrogen carbonate solution was added to the reaction solution, the mixture was stirred for 1 hour, and the layers were separated to remove water. The organic layer was washed twice with water, and then the solvent was concentrated under reduced pressure to obtain 36 g of the title compound.

3-2) 화합물 105의 합성3-2) Synthesis of Compound 105

100ml 3구 둥근바닥플라스크에 중간체 12(1.6 g), 나프탈렌-1-일 보론산(0.65 g), 테트라하이드로퓨란(20 ml), 탄산칼륨(1 g) 및 물(10 ml)을 넣고 교반하였다. 이 혼합액에 테트라키스(트리페닐포스핀)팔라듐(0)(0.2 g)을 넣고 80℃로 가열하였다. 반응액을 냉각한 후 여과하고 결정을 아세톤으로 씻어준 후 염화메틸렌으로 재결정하여 표제 화합물 1.6g을 얻었다.In a 100 ml three-necked round bottom flask, intermediate 12 (1.6 g), naphthalen-1-yl boronic acid (0.65 g), tetrahydrofuran (20 ml), potassium carbonate (1 g) and water (10 ml) were added and stirred. . Tetrakis (triphenylphosphine) palladium (0) (0.2 g) was added to this mixed solution, and it heated at 80 degreeC. The reaction solution was cooled, filtered and the crystals were washed with acetone and recrystallized with methylene chloride to obtain 1.6 g of the title compound.

1H-NMR(CDCl3, 500MHz) 1H(d, 8.53529~8.51727), 1H(d, 8.44197~8.42649), 3H(t, 8.01437~7.98325), 3H(m, 7.94330~7.92101), 1H(d, 7.65249~7.63733), 5H(m, 7.60906~7.53009), 1H(t, 7.48996~7.4596), 4H(m, 7.43566~7.36620), 2H(m, 7.32983~7.27914), 6H(m, 7.18386~7.09477), 1H(d, 7.04772~7.03182), 1H(t, 6.95497~6.92397), 1H(d, 6.58601~6.57122) 1 H-NMR (CDCl 3 , 500 MHz) 1H (d, 8.53529-8.51727), 1H (d, 8.44197-8.42649), 3H (t, 8.01437-7.83325), 3H (m, 7.94330-7.82101), 1H (d, 7.65249 ~ 7.63733), 5H (m, 7.60906 ~ 7.53009), 1H (t, 7.48996 ~ 7.4596), 4H (m, 7.43566 ~ 7.36620), 2H (m, 7.32983 ~ 7.27914), 6H (m, 7.18386 ~ 7.09477), 1H (d, 7.04772 ~ 7.03182), 1H (t, 6.95497 ~ 6.92397), 1H (d, 6.58601 ~ 6.57122)

EI-MS : m/z 618(M+)EI-MS: m / z 618 (M +)

3-3) 화합물 106의 합성3-3) Synthesis of Compound 106

100ml 3구 둥근바닥플라스크에 중간체 12(1.6 g), 나프탈렌-1-일 보론산(0.65 g), 테트라하이드로퓨란(20 ml), 탄산칼륨(1 g) 및 물(10 ml)을 넣고 교반 하였다. 이 혼합액에 테트라키스(트리페닐포스핀)팔라듐(0)(0.2 g)을 넣고 80℃로 가열하였다. 반응액을 냉각한 후 여과하고 결정을 아세톤으로 씻어준 후 염화메틸렌으로 재결정하여 표제 화합물 1.3g을 얻었다.In a 100 ml three-necked round bottom flask, intermediate 12 (1.6 g), naphthalen-1-yl boronic acid (0.65 g), tetrahydrofuran (20 ml), potassium carbonate (1 g) and water (10 ml) were added and stirred. . Tetrakis (triphenylphosphine) palladium (0) (0.2 g) was added to this mixed solution, and it heated at 80 degreeC. The reaction solution was cooled, filtered and the crystals were washed with acetone and recrystallized with methylene chloride to obtain 1.3 g of the title compound.

1H-NMR(CDCl3, 500MHz) 1H(d, 8.511~8.489), 1H(d, 8.422~8.403), 3H(d, 8.013~7.993), 1H(s, 7.968), 4H(m, 7.968~7.885), 3H(m, 7.709~7.670), 4H(m, 7.572~7.523), 2H(d, 7.420~7.401), 2H(d, 7.379~7.359), 1H(d, 7.309~7.291), 5H(m, 7.155~7.083), 2H(t, 7.072~7.034), 1H(d, 6.622~6.603) 1 H-NMR (CDCl 3 , 500MHz) 1H (d, 8.511-8.489), 1H (d, 8.422-8.403), 3H (d, 8.013 ~ 7.993), 1H (s, 7.968), 4H (m, 7.968 ~ 7.885), 3H (m, 7.709 ~ 7.670), 4H (m, 7.572 ~ 7.523), 2H (d, 7.420 ~ 7.401), 2H (d, 7.379 ~ 7.359), 1H (d, 7.309 ~ 7.291), 5H ( m, 7.155 ~ 7.083), 2H (t, 7.072 ~ 7.034), 1H (d, 6.622 ~ 6.603)

EI-MS : m/z 618(M+)EI-MS: m / z 618 (M +)

3-4) 화합물 107의 합성3-4) Synthesis of Compound 107

100ml 3구 둥근바닥플라스크에 중간체 12(1.6 g), 페난트렌-9-일 보론산(0.8 g), 테트라하이드로퓨란(20 ml), 탄산칼륨(1 g) 및 물(10 ml)을 넣고 교반하였다. 이 혼합액에 테트라키스(트리페닐포스핀)팔라듐(0)(0.2 g)을 넣고 80℃로 가열하였다. 반응액을 냉각한 후 여과하고 결정을 아세톤으로 씻어준 후 염화메틸렌으로 재결정하여 표제 화합물 1.7g을 얻었다.In a 100 ml three-necked round bottom flask, intermediate 12 (1.6 g), phenanthrene-9-yl boronic acid (0.8 g), tetrahydrofuran (20 ml), potassium carbonate (1 g) and water (10 ml) were added and stirred. It was. Tetrakis (triphenylphosphine) palladium (0) (0.2 g) was added to this mixed solution, and it heated at 80 degreeC. The reaction solution was cooled, filtered and the crystals were washed with acetone and recrystallized with methylene chloride to obtain 1.7 g of the title compound.

1H-NMR(CDCl3, 500MHz) 2H(t, 8.81288~8.77500), 1H(d, 8.55131~8.53321), 1H(d, 8.46897~8.45351), 3H(m, 8.01953~7.98434), 2H(m, 7.93261~7.89642), 1H(s, 7.83116), 2H(t, 7.72631~7.7013), 2H(m, 7.7652~7.62284), 3H(t, 7.59702~7.56190), 5H(m, 7.42695~7.37036), 1H(d, 7.3153~7.29849), 1H(d, 7.24387~7.22756), 5H(m, 7.16763~7.09821), 1H(d, 7.05443~7.03867), 1H(d, 6.93049~6.91430), 1H(d, 6.59103~6.57612) 1 H-NMR (CDCl 3 , 500 MHz) 2H (t, 8.81288-8.77500), 1H (d, 8.55131-8.53321), 1H (d, 8.46897-8.45351), 3H (m, 8.01953-7.8434), 2H (m, 7.93261 ~ 7.89642), 1H (s, 7.83116), 2H (t, 7.72631 ~ 7.7013), 2H (m, 7.7652 ~ 7.62284), 3H (t, 7.59702 ~ 7.56190), 5H (m, 7.42695 ~ 7.37036), 1H ( d, 7.3153 ~ 7.29849), 1H (d, 7.24387 ~ 7.22756), 5H (m, 7.16763 ~ 7.09821), 1H (d, 7.05443 ~ 7.03867), 1H (d, 6.93049 ~ 6.91430), 1H (d, 6.59103 ~ 6.57612 )

EI-MS : m/z 669(M+)EI-MS: m / z 669 (M +)

3-5) 화합물 110의 합성3-5) Synthesis of Compound 110

100ml 3구 둥근바닥플라스크에 중간체 12(1.6 g), 4-(1-나프탈렌)-1-페닐보론산(0.86 g), 테트라하이드로퓨란(20 ml), 탄산칼륨(1 g) 및 물(10 ml)을 넣고 교반하였다. 이 혼합액에 테트라키스(트리페닐포스핀)팔라듐(0)(0.2 g)을 넣고 80℃로 가열하였다. 반응액을 냉각한 후 여과하고 결정을 아세톤으로 씻어준 후 염화메틸렌으로 재결정하여 표제 화합물 1.5g을 얻었다.In a 100 ml three-necked round bottom flask, Intermediate 12 (1.6 g), 4- (1-naphthalene) -1-phenylboronic acid (0.86 g), tetrahydrofuran (20 ml), potassium carbonate (1 g) and water (10 ml) was added and stirred. Tetrakis (triphenylphosphine) palladium (0) (0.2 g) was added to this mixed solution, and it heated at 80 degreeC. The reaction solution was cooled, filtered and the crystals were washed with acetone and recrystallized with methylene chloride to obtain 1.5 g of the title compound.

1H-NMR(CDCl3, 500MHz) (1H, d, 8.50970∼8.49168), (1H, d, 8.42353, 8.4.794), (1H, d, 8.07996, 8.06194), (2H, d, 8.01643, 8.00113), (1H, d, 7.98321, 7.96542), (3H, m, 7.94593∼7.89355), (1H, d, 7.84365, 7.82718), (5H, m, 7.69204∼7.61719), (6H, d, 7.58142∼7.47368), (4H, m, 7.41957∼7.35884), (1H, t, 7.30467∼7.27303), (5H, m, 7.16011∼7.09383), (2H, d, 7.05529, 7.04019), (1H, d, 6.64619, 6.63128) 1 H-NMR (CDCl 3 , 500 MHz) (1H, d, 8.50970-8.49168), (1H, d, 8.42353, 8.4.794), (1H, d, 8.07996, 8.06194), (2H, d, 8.01643, 8.00113 ), (1H, d, 7.98321, 7.96542), (3H, m, 7.94593-7.89355), (1H, d, 7.84365, 7.82718), (5H, m, 7.69204-7.7.61719), (6H, d, 7.58142-7.47368 ), (4H, m, 7.41957-7.5884), (1H, t, 7.30467-7.27303), (5H, m, 7.16011-7.09383), (2H, d, 7.05529, 7.04019), (1H, d, 6.64619, 6.63128 )

EI-MS : m/z 695(M+)EI-MS: m / z 695 (M +)

3-6) 화합물 112의 합성3-6) Synthesis of Compound 112

100ml 3구 둥근바닥플라스크에 중간체 12(1.6 g), 3,5-다이페닐-1-벤젠보론산(1.0 g), 테트라하이드로퓨란(20 ml), 탄산칼륨(1 g) 및 물(10 ml)을 넣고 교반하였다. 이 혼합액에 테트라키스(트리페닐포스핀)팔라듐(0)(0.2 g)을 넣고 80℃로 가열하였다. 반응액을 냉각한 후 여과하고 결정을 아세톤으로 씻어준 후 염화메틸렌으로 재결정하여 표제 화합물 1.6g을 얻었다.In a 100 ml three-necked round bottom flask, intermediate 12 (1.6 g), 3,5-diphenyl-1-benzeneboronic acid (1.0 g), tetrahydrofuran (20 ml), potassium carbonate (1 g) and water (10 ml) ) Was added and stirred. Tetrakis (triphenylphosphine) palladium (0) (0.2 g) was added to this mixed solution, and it heated at 80 degreeC. The reaction solution was cooled, filtered and the crystals were washed with acetone and recrystallized with methylene chloride to obtain 1.6 g of the title compound.

1H-NMR(CDCl3, 500MHz) 1H(d, 8.510~8.487), 1H(d, 8.421~8.401), 3H(t, 8.013~7.967), 2H(d, 7.914~7.880), 1H(d, 7.826~7.809), 2H(s, 7.764), 5H(m, 7.724~7.687), 2H(d, 7.567~7.549), 4H(m, 7.484~7.447), 6H(m, 7.394~7.358), 1H(d, 7.275~7.290), 1H(d, 7.135~7.155), 4H(m, 7.131~7.088), 2H(d, 7.049~7.030), 1H(d, 6.647~6.631) 1 H-NMR (CDCl 3 , 500 MHz) 1H (d, 8.510-8.487), 1H (d, 8.421-8.401), 3H (t, 8.013-7.967), 2H (d, 7.914-7.880), 1H (d, 7.826 ~ 7.809), 2H (s, 7.764), 5H (m, 7.724 ~ 7.687), 2H (d, 7.567 ~ 7.549), 4H (m, 7.484 ~ 7.447), 6H (m, 7.394 ~ 7.358), 1H ( d, 7.275 ~ 7.290), 1H (d, 7.135 ~ 7.155), 4H (m, 7.131 ~ 7.088), 2H (d, 7.049 ~ 7.030), 1H (d, 6.647 ~ 6.631)

EI-MS : m/z 721(M+)EI-MS: m / z 721 (M +)

3-7) 화합물 94의 합성3-7) Synthesis of Compound 94

100ml 3구 둥근바닥플라스크에 중간체 12(2 g), p,p'-다이톨릴아민(0.83 g), 소디움-t-뷰톡사이드(0.5 g), 톨루엔(30 ml)을 넣은 후 30분간 아르곤가스 분위기하에서 교반하였다. 이후 팔라듐아세테이트(0.01 g)와 트리(t-뷰틸)포스핀(0.03 g)을 넣고 24시간 동안 환류교반하였다. 반응액을 냉각한 후 증류수와 염화메틸렌으로 추출하고 염화메틸렌/헥산의 비율이 1/10인 전개용매로 컬럼 정제하여 표제 화 합물 1.3 g을 얻었다.Argon gas for 30 minutes after adding Intermediate 12 (2 g), p, p'-ditolylamine (0.83 g), sodium t-butoxide (0.5 g) and toluene (30 ml) in a 100 ml three-necked round bottom flask It stirred under atmosphere. Then, palladium acetate (0.01 g) and tri (t-butyl) phosphine (0.03 g) were added thereto, and the mixture was stirred under reflux for 24 hours. After cooling the reaction solution, the mixture was extracted with distilled water and methylene chloride and column purified with a developing solvent having a ratio of methylene chloride / hexane of 1/10 to obtain 1.3 g of the title compound.

1H-NMR(CDCl3, 500MHz) 1H(d, 8.40662~8.38865), 1H(d, 8.27474~8.25850), 2H(d, 7.98672~7.97146), 1H(d, 7.94144~7.92362), 1H(s, 7.88668), 1H(d, 7.70756~7.69126), 2H(d, 7.55254~7.53757), 5H(m, 7.40997~7.35293), 1H(d, 7.29707~7.28230), 74H(t, 7.11244~7.08420), 11H(m, 7.02547~6.95006), 1H(d, 6.54138~6.52653), 6H(s, 2.27060) 1 H-NMR (CDCl 3 , 500 MHz) 1H (d, 8.40662-8.38865), 1H (d, 8.27474-8.25850), 2H (d, 7.98672-7.97146), 1H (d, 7.94144-7.92362), 1H (s, 7.88668), 1H (d, 7.70756 ~ 7.69126), 2H (d, 7.55254 ~ 7.53757), 5H (m, 7.40997 ~ 7.35293), 1H (d, 7.29707 ~ 7.28230), 74H (t, 7.11244 ~ 7.08420), 11H ( m, 7.02547-6.95006), 1H (d, 6.54138-6.52653), 6H (s, 2.27060)

EI-MS : m/z 688(M+)EI-MS: m / z 688 (M +)

실시예 4 : 본 발명의 화합물 79, 127, 135, 136, 142, 149의 합성 (하기 반응식 8 참조)Example 4 Synthesis of Compounds 79, 127, 135, 136, 142, 149 of the Invention (See Scheme 8 below)

Figure 112009059119266-PAT00027
Figure 112009059119266-PAT00027

4-1) 중간체 13의 합성  4-1) Synthesis of Intermediate 13

5000ml 3구 둥근바닥플라스크에 화합물 60(73 g) 및 클로로폼(3000 ml)을 넣고 상온에서 브롬(22 g)을 천천히 첨가하고 12시간 동안 교반하였다. 이 반응액에 탄산수소나트륨 수용액을 첨가하고 1시간 동안 교반한 후 층분리하여 물을 제거하고, 유기층을 물로 2 회 더 씻어준 후 용매를 감압 농축 제거하여 표제 화합물 69g 을 얻었다.Compound 60 (73 g) and chloroform (3000 ml) were added to a 5000 ml three-necked round bottom flask, and bromine (22 g) was slowly added at room temperature and stirred for 12 hours. An aqueous sodium hydrogen carbonate solution was added to the reaction solution, the mixture was stirred for 1 hour, and the layers were separated to remove water. The organic layer was washed twice with water, and then the solvent was concentrated under reduced pressure to obtain 69 g of the title compound.

4-2) 화합물 127의 합성4-2) Synthesis of Compound 127

100ml 3구 둥근바닥플라스크에 중간체 13(3 g), 페닐보론산(0.65 g), 테트라하이드로퓨란(30 ml), 탄산칼륨(1.5 g) 및 물(15 ml)을 넣고 교반하였다. 이 혼합액에 테트라키스(트리페닐포스핀)팔라듐(0)(0.3 g)을 넣고 80℃로 가열하였다. 반응액을 냉각한 후 여과하고 결정을 아세톤으로 씻어준 후 염화메틸렌으로 재결정하여 표제 화합물 1.9g을 얻었다.In a 100 ml three-necked round bottom flask, intermediate 13 (3 g), phenylboronic acid (0.65 g), tetrahydrofuran (30 ml), potassium carbonate (1.5 g) and water (15 ml) were added and stirred. Tetrakis (triphenylphosphine) palladium (0) (0.3 g) was added to this mixed solution, and it heated at 80 degreeC. The reaction solution was cooled, filtered and the crystals were washed with acetone and recrystallized with methylene chloride to obtain 1.9 g of the title compound.

1H-NMR(CDCl3, 500MHz) 1H(d, 8.51199~8.49398), 1H(d, 8.39795~8.38243), 5H(m, 8.04242~7.99982), 3H(m, 7.86489~7.81868), 1H(d, 7.74021~7.72496), 1H(d, 7.67810~7.66162), 1H(d, 7.59553~7.58028), 2H(d, 7.54640~7.53246), 2H(d, 7.51086~7.48617), 5H(m, 7.48102~7.39640), 1H(d, 7.29018~7.27476), 3H(m, 7.09912~7.07372), 2H(d, 7.05356~7.03849), 1H(d, 6.62035~6.60552) 1 H-NMR (CDCl 3 , 500 MHz) 1H (d, 8.51199-8.49398), 1H (d, 8.39795-8.38243), 5H (m, 8.04242-7.99982), 3H (m, 7.86489-7.81868), 1H (d, 7.74021 ~ 7.72496), 1H (d, 7.67810 ~ 7.66162), 1H (d, 7.59553 ~ 7.58028), 2H (d, 7.54640 ~ 7.53246), 2H (d, 7.51086 ~ 7.48617), 5H (m, 7.48102 ~ 7.39640), 1H (d, 7.29018 ~ 7.27476), 3H (m, 7.09912 ~ 7.07372), 2H (d, 7.05356 ~ 7.03849), 1H (d, 6.62035 ~ 6.60552)

EI-MS : m/z 619(M+)EI-MS: m / z 619 (M +)

4-3) 화합물 142의 합성4-3) Synthesis of Compound 142

100ml 3구 둥근바닥플라스크에 중간체 13(3 g), 나프탈렌-1-일 보론산(0.86 g), 테트라하이드로퓨란(30 ml), 탄산칼륨(1.5 g) 및 물(15 ml)을 넣고 교반하였다. 이 혼합액에 테트라키스(트리페닐포스핀)팔라듐(0)(0.3 g)을 넣고 80℃로 가열 하였다. 반응액을 냉각한 후 여과하고 결정을 아세톤으로 씻어준 후 염화메틸렌으로 재결정하여 표제 화합물 2.5g을 얻었다.In a 100 ml three-necked round bottom flask, intermediate 13 (3 g), naphthalen-1-yl boronic acid (0.86 g), tetrahydrofuran (30 ml), potassium carbonate (1.5 g) and water (15 ml) were added and stirred. . Tetrakis (triphenylphosphine) palladium (0) (0.3 g) was added to this mixture, and it heated at 80 degreeC. The reaction solution was cooled, filtered and the crystals were washed with acetone and recrystallized with methylene chloride to obtain 2.5 g of the title compound.

1H-NMR(CDCl3, 500MHz) 1H(d, 8.55194~8.53389), 1H(d, 8.44938~8.43389), 5H(m, 8.05377~7.99422), 2H(m, 7.94290~7.92670), 3H(m, 7.86461~7.81818), 1H(d, 7.75609~7.73974), 1H(d, 7.65462~7.63952), 1H(t, 7.60321)~7.57434), 2H(d, 7.54678~7.53262), 5H(m, 7.47213~7.37454), 2H(m. 7.32543~7.26461), 1H(d, 7.22727~7.21276), 4H(d, 7.17476~7.10074), 1H(d, 7.06149~7.04726), 1H(t, 6.95780~6.92682), 1H(d, 6.59686~6.58235) 1 H-NMR (CDCl 3 , 500 MHz) 1H (d, 8.55194 to 8.53389), 1H (d, 8.44938 to 8.43389), 5H (m, 8.05377 to 7.9422), 2H (m, 7.94290 to 7.72670), 3H (m, 7.86461 ~ 7.81818), 1H (d, 7.75609 ~ 7.73974), 1H (d, 7.65462 ~ 7.63952), 1H (t, 7.60321) ~ 7.57434), 2H (d, 7.54678 ~ 7.53262), 5H (m, 7.47213 ~ 7.37454) , 2H (m. 7.32543 ~ 7.26461), 1H (d, 7.22727 ~ 7.21276), 4H (d, 7.17476 ~ 7.10074), 1H (d, 7.06149 ~ 7.04726), 1H (t, 6.95780 ~ 6.92682), 1H (d, 6.59686-6.58235)

EI-MS : m/z 669 (M+)EI-MS: m / z 669 (M +)

4-4) 화합물 79의 합성4-4) Synthesis of Compound 79

100ml 3구 둥근바닥플라스크에 중간체 13(3 g), 나프탈렌-2-일 보론산(0.86 g), 테트라하이드로퓨란(30 ml), 탄산칼륨(1.5 g) 및 물(15 ml)을 넣고 교반하였다. 이 혼합액에 테트라키스(트리페닐포스핀)팔라듐(0)(0.3 g)을 넣고 80℃로 가열하였다. 반응액을 냉각한 후 여과하고 결정을 아세톤으로 씻어준 후 염화메틸렌으로 재결정하여 표제 화합물 2.8g을 얻었다.In a 100 ml three-necked round bottom flask, intermediate 13 (3 g), naphthalen-2-yl boronic acid (0.86 g), tetrahydrofuran (30 ml), potassium carbonate (1.5 g) and water (15 ml) were added and stirred. . Tetrakis (triphenylphosphine) palladium (0) (0.3 g) was added to this mixed solution, and it heated at 80 degreeC. The reaction solution was cooled, filtered and the crystals were washed with acetone and recrystallized with methylene chloride to obtain 2.8 g of the title compound.

1H-NMR(CDCl3, 500MHz) 1H(d, 8.52948~8.51151), 1H(d, 8.43140~8.41591), 6H(m, 8.04919~8.00992), 1H(d, 7.96729~7.95045), 2H(m, 7.93395~7.88795), 3H(m, 7.86613~7.81975), 4H(m, 7.73449~7.66229), 2H(m, 7.54594~7.52709), 2H(m, 7.4775~7.44520) 2H(t, 7.43037~7.40046), 1H(d, 7.28198~7.26668), 1H(d, 7.22398~7.20838), 5H(m, 7.13732~7.05340), 1H(d, 6.63504~6.62016) 1 H-NMR (CDCl 3 , 500 MHz) 1H (d, 8.52948-8.51151), 1H (d, 8.43140-8.41591), 6H (m, 8.04919-8.00992), 1H (d, 7.96729-7.91745), 2H (m, 7.93395-7.88795), 3H (m, 7.86613-7.81975), 4H (m, 7.73449-7.6229), 2H (m, 7.54594-7.52709), 2H (m, 7.4775-7.44520) 2H (t, 7.43037-7.40046), 1H (d, 7.28198-7.26668), 1H (d, 7.22398-7.20838), 5H (m, 7.13732-7.05340), 1H (d, 6.63504-6.62016)

EI-MS : m/z 669(M+)EI-MS: m / z 669 (M +)

4-5) 화합물 149의 합성 4-5) Synthesis of Compound 149

100ml 3구 둥근바닥플라스크에 중간체 13(3 g), 3-(4,4,5,5-테트라메틸-1,3,2-다이옥사보로란-2-일)피리딘(1.2 g), 톨루엔(60 ml), 에탄올(20 ml), 탄산칼륨(3.2 g) 및 물(12 ml)을 넣고 교반하였다. 이 혼합액에 테트라키스(트리페닐포스핀)팔라듐(0)(0.3 g)을 넣고 80℃로 가열하였다. 반응액을 냉각한 후 여과하여 표제 화합물 1.9g을 얻었다.In a 100 ml three-necked round-bottom flask, intermediate 13 (3 g), 3- (4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl) pyridine (1.2 g), toluene (60 ml), ethanol (20 ml), potassium carbonate (3.2 g) and water (12 ml) were added thereto and stirred. Tetrakis (triphenylphosphine) palladium (0) (0.3 g) was added to this mixed solution, and it heated at 80 degreeC. The reaction solution was cooled and filtered to obtain 1.9 g of the title compound.

1H NMR(CDCl3, 500MHz) 1H(s, 8.80024), 1H(d, 8.68563~8.67595), 1H(d, 8.49616~8.47943), 1H(d, 8.40828~8.39219), 5H(m, 8.04083~8.00097), 4H(m, 7.85855~7.81232), 1H(d, 7.73003~7.713519), 2H(t, 7.58126~7.56067), 5H(m, 7.46237~7.39811), 1H(d, 7.26325~7.25291), 1H(d, 7.21617~7.19845), 3H(m, 7.12127~7.09455), 2H(d, 7.03732~7.02221), 1H(d, 6.65279~6.63799) 1 H NMR (CDCl 3 , 500 MHz) 1H (s, 8.80024), 1H (d, 8.68563-8.67595), 1H (d, 8.49616-8.47943), 1H (d, 8.40828-8.39219), 5H (m, 8.04083-8.00097 ), 4H (m, 7.85855-7.81232), 1H (d, 7.73003-7.713519), 2H (t, 7.58126-7.56067), 5H (m, 7.46237-7.39811), 1H (d, 7.26325-7.25291), 1H (d , 7.21617 ~ 7.19845), 3H (m, 7.12127 ~ 7.09455), 2H (d, 7.03732 ~ 7.02221), 1H (d, 6.65279 ~ 6.63799)

EI-MS : m/z 620(M+)EI-MS: m / z 620 (M +)

4-6) 화합물 135의 합성4-6) Synthesis of Compound 135

100ml 3구 둥근바닥플라스크에 중간체 13(3 g) 및 테트라하이드로퓨란(60 ml)를 넣은 후 아르곤 분위기 하에서 교반하고 혼합액의 온도를 -78℃로 낮추어 주었다. 여기에 n-뷰틸리튬(1.6 M)(3.6 ml)을 천천히 첨가한 후 2시간 동안 교반하였다. 다이페닐클로로포스핀(1.2 g)을 테트라하이드로퓨란 10ml에 녹인 용액을 상기 혼합액에 천천히 투입하고 혼합액을 -78℃에서 12시간 동안 교반한 후 상온으로 온도를 상승시켜 2시간동안 반응시켰다. 반응액에 증류수와 아세트산에틸을 넣어 추출하였다. 아세트산에틸/염화메틸렌의 비율이 1/1인 전개용매를 사용하여 컬럼 정제하여 표제 화합물 3 g을 얻었다.Intermediate 13 (3 g) and tetrahydrofuran (60 ml) were added to a 100 ml three-necked round bottom flask, and the mixture was stirred under an argon atmosphere and the temperature of the mixed solution was lowered to -78 ° C. N-butyllithium (1.6 M) (3.6 ml) was slowly added thereto, followed by stirring for 2 hours. A solution of diphenylchlorophosphine (1.2 g) dissolved in 10 ml of tetrahydrofuran was slowly added to the mixture, the mixture was stirred at -78 ° C for 12 hours, and then heated to room temperature to react for 2 hours. Distilled water and ethyl acetate were added to the reaction solution and extracted. 3 g of the title compound was obtained by column purification using a developing solvent having an ethyl acetate / methylene chloride ratio of 1/1.

1H-NMR(CDCl3, 500MHz) 1H(d, 8.39612~8.38187), 1H(d, 8.32135~8.21172), 1 H-NMR (CDCl 3 , 500 MHz) 1H (d, 8.39612-8.38187), 1H (d, 8.32135-8.21172),

1H(d, 8.19516~8.17332), 5H(t, 8.00601~7.97697), 9H(m, 7.85797~7.81232), 2H(t, 7.72558~7.70863), 7H(m, 7.49221~7.44267), 2H(t, 7.41666~7.37143), 1H(d, 7.19087~7.15188), 3H(t, 7.11421~7.08367), 2H(d, 7.00232~6.96912), 1H(d, 6.63155~6.59686)1H (d, 8.19516 ~ 8.17332), 5H (t, 8.00601 ~ 7.97697), 9H (m, 7.85797 ~ 7.81232), 2H (t, 7.72558 ~ 7.70863), 7H (m, 7.49221 ~ 7.44267), 2H (t, 7.41666 ~ 7.37143), 1H (d, 7.19087 ~ 7.15188), 3H (t, 7.11421 ~ 7.08367), 2H (d, 7.00232 ~ 6.96912), 1H (d, 6.63155 ~ 6.59686)

EI-MS : m/z 727(M+)EI-MS: m / z 727 (M +)

4-7) 화합물 136의 합성 4-7) Synthesis of Compound 136

100ml 둥근바닥플라스크에 화합물 135(3 g), 염화메틸렌(30 ml) 및 30% 과산화수소(6 ml)를 넣은 후 상온에서 약 3시간동안 교반하였다. 반응물에 물(30 ml)을 첨가하여 추출한 후 다시 5% NaOH 수용액으로 수차례 세척한 후 유기층을 무수 황 산마그네슘으로 건조시킨다. 아세트산에틸/염화메틸렌의 비율이 1/1인 전개용매를 사용하여 컬럼 정제하여 표제 화합물 2.4 g을 얻었다.Compound 135 (3 g), methylene chloride (30 ml) and 30% hydrogen peroxide (6 ml) were added to a 100 ml round bottom flask, followed by stirring at room temperature for about 3 hours. Water (30 ml) was added to the reaction mixture, followed by washing several times with 5% aqueous NaOH solution. The organic layer was dried over anhydrous magnesium sulfate. 2.4 g of the title compound was obtained by column purification using a developing solvent having an ethyl acetate / methylene chloride ratio of 1/1.

1H-NMR(CDCl3, 500MHz) : 1H(d, 8.39612~8.37866), 1H(d, 8.3480~8.32321), 1 H-NMR (CDCl 3 , 500 MHz): 1H (d, 8.39612-8.37866), 1H (d, 8.3480-8.32321),

1H(d, 8.21835~8.20331), 5H(t, 8.02985~7.98276), 9H(m, 7.86041~7.70444), 2H(t, 7.58578~7.55606), 7H(m, 7.50613~7.43728), 2H(t, 7.41221~7.38188), 1H(d, 7.21632~7.19818), 3H(t, 7.10778~7.07620), 2H(d, 6.94427~6.92934), 1H(d, 6.61311~6.59815)1H (d, 8.21835 ~ 8.20331), 5H (t, 8.02985 ~ 7.98276), 9H (m, 7.86041 ~ 7.70444), 2H (t, 7.58578 ~ 7.55606), 7H (m, 7.50613 ~ 7.43728), 2H (t, 7.41221 ~ 7.38188), 1H (d, 7.21632 ~ 7.19818), 3H (t, 7.10778 ~ 7.07620), 2H (d, 6.94427 ~ 6.92934), 1H (d, 6.61311 ~ 6.59815)

EI-MS : m/z 743(M+)EI-MS: m / z 743 (M +)

실시예 5 : 본 발명의 화합물 257, 259, 260의 합성 (하기 반응식 9 참조)Example 5 Synthesis of Compounds 257, 259, 260 of the Invention (See Scheme 9 below)

Figure 112009059119266-PAT00028
Figure 112009059119266-PAT00028

상기 식에서, OTf는 트리플루오로메탄설포닐이다.Wherein OTf is trifluoromethanesulfonyl.

5-1) 중간체 14의 합성5-1) Synthesis of Intermediate 14

250ml 3구 둥근바닥플라스크에 2-메틸나프탈렌-1-일 보론산(15 g), 1-브로모-6-페닐나프탈렌-2-일 트리플루오로메탄설포네이트(35.5 g), 테트라하이드로퓨 란(100 ml), 탄산칼륨(13 g) 및 물(50 ml)을 넣고 교반하였다. 이 혼합액에 테트라키스(트리페닐포스핀)팔라듐(0)(4.7 g)을 넣고 80℃로 가열하였다. 반응액을 냉각한 후 증류수(100 ml)로 2 회 세척한 후 다시 에탄올(200 ml)로 세척하여 표제 화합물 22g을 얻었다.2-methylnaphthalen-1-yl boronic acid (15 g), 1-bromo-6-phenylnaphthalen-2-yl trifluoromethanesulfonate (35.5 g), tetrahydrofuran in a 250 ml three-necked round bottom flask (100 ml), potassium carbonate (13 g) and water (50 ml) were added thereto and stirred. Tetrakis (triphenylphosphine) palladium (0) (4.7 g) was put into this mixed solution, and it heated at 80 degreeC. After cooling the reaction solution, washed twice with distilled water (100 ml) and then again with ethanol (200 ml) to give 22g of the title compound.

5-2) 중간체 15의 합성5-2) Synthesis of Intermediate 15

500ml 3구 둥근바닥플라스크에 중간체 14(22 g) 및 테트라하이드로퓨란(220 ml)를 넣은 후 아르곤 분위기 하에서 교반하고 혼합액의 온도를 -78℃로 낮추어 주었다. 여기에 n-뷰틸리튬(1.6M)(36 ml)를 천천히 첨가한 후 2시간 동안 교반하였다. 플루오레논(9.4 g)을 테트라하이드로퓨란(30 ml)에 녹인 용액을 상기 혼합액에 천천히 투입하고 혼합액의 온도를 상온으로 승온한 후 12시간 동안 교반하였다. 반응액에 물(20 ml)을 넣고 2시간 동안 교반하였다. 반응액을 층분리하여 물을 제거하고 유기층을 냉각한 후 결정을 여과하여 표제 화합물 29g을 얻었다.Intermediate 14 (22 g) and tetrahydrofuran (220 ml) were added to a 500 ml three-necked round bottom flask, and the mixture was stirred under an argon atmosphere and the temperature of the mixed solution was lowered to -78 ° C. N -butyllithium (1.6M) (36 ml) was slowly added thereto, followed by stirring for 2 hours. A solution of fluorenone (9.4 g) dissolved in tetrahydrofuran (30 ml) was slowly added to the mixed solution, and the temperature of the mixed solution was raised to room temperature, followed by stirring for 12 hours. Water (20 ml) was added to the reaction solution and stirred for 2 hours. The reaction solution was separated and the water was removed, the organic layer was cooled, and the crystals were filtered to obtain 29 g of the title compound.

5-3) 화합물 257의 합성5-3) Synthesis of Compound 257

100ml 3구 둥근바닥플라스크에 중간체 15(29 g), 아세트산(300 ml) 및 염산(25 ml)을 첨가한 후 110℃에서 8시간 동안 교반한 다음 냉각하였다. 반응액을 여과하고 물 및 메탄올로 순차적으로 씻어준 다음 건조하여 흰색 분말의 표제 화합물 21 g을 얻었다.Intermediate 15 (29 g), acetic acid (300 ml) and hydrochloric acid (25 ml) were added to a 100 ml three-necked round bottom flask, followed by stirring at 110 ° C. for 8 hours and then cooling. The reaction solution was filtered, washed sequentially with water and methanol and dried to obtain 21 g of the title compound as a white powder.

1H NMR(CDCl3, 500MHz) : 1H(d, 8.32543~8.30754), 1H(d, 8.19886~8.18065), 3H(t, 8.01560~7.96865), 3H(m, 7.94767~7.88628), 2H(d, 7.54172~7.52680), 4H(m, 7.40576~7.34870), 2H(m, 7.29556~7.21832), 4H(m, 7.14566~7.04327), 2H(d, 6.94548~6.93466), 1H(d, 6.65264~6.63758), 3H(s, 2.68356) 1 H NMR (CDCl 3 , 500MHz): 1H (d, 8.32543 ~ 8.30754), 1H (d, 8.19886 ~ 8.18065), 3H (t, 8.01560 ~ 7.96865), 3H (m, 7.94767 ~ 7.88628), 2H (d, 7.54172 ~ 7.52680), 4H (m, 7.40576 ~ 7.34870), 2H (m, 7.29556 ~ 7.21832), 4H (m, 7.14566 ~ 7.04327), 2H (d, 6.94548 ~ 6.93466), 1H (d, 6.65264 ~ 6.63758), 3H (s, 2.68356)

EI-MS : m/z 507(M+)EI-MS: m / z 507 (M +)

5-4) 중간체 16의 합성5-4) Synthesis of Intermediate 16

2000ml 3구 둥근바닥플라스크에 화합물 257(21 g) 및 클로로폼(1200 ml)를 넣고 상온에서 브롬(9.2 g)을 천천히 첨가하고 12시간 동안 교반하였다. 이 반응액에 탄산수소나트륨 수용액을 첨가하고 1시간 동안 교반한 후 층분리하여 물을 제거하고, 유기층을 물로 2 회 더 씻어준 후 용매를 감압 농축 제거하여 표제 화합물 18 g을 얻었다.Compound 257 (21 g) and chloroform (1200 ml) were added to a 2000 ml three-necked round bottom flask, and bromine (9.2 g) was slowly added at room temperature and stirred for 12 hours. An aqueous sodium hydrogen carbonate solution was added to the reaction solution, the mixture was stirred for 1 hour, and the layers were separated to remove water. The organic layer was washed twice with water, and then the solvent was concentrated under reduced pressure to obtain 18 g of the title compound.

5-5) 화합물 259의 합성5-5) Synthesis of Compound 259

250ml 3구 둥근바닥플라스크에 중간체 16(10 g), 페난트렌-9-일 보론산(4.2 g), 테트라하이드로퓨란(100 ml), 탄산칼륨(3.9 g) 및 물(40 ml)를 넣고 교반하였다. 이 혼합액에 테트라키스(트리페닐포스핀)팔라듐(0)(1.1 g)을 넣고 80℃로 가열하였다. 반응액을 냉각한 후 여과하고 결정을 아세톤으로 씻어준 후 염화메틸렌으로 재결정하여 표제 화합물 13g을 얻었다.In a 250 ml three-necked round bottom flask, intermediate 16 (10 g), phenanthrene-9-yl boronic acid (4.2 g), tetrahydrofuran (100 ml), potassium carbonate (3.9 g) and water (40 ml) were added and stirred. It was. Tetrakis (triphenylphosphine) palladium (0) (1.1 g) was added to this mixed solution, and it heated at 80 degreeC. The reaction solution was cooled, filtered, and the crystals were washed with acetone and recrystallized with methylene chloride to obtain 13 g of the title compound.

1H NMR(CDCl3, 500MHz): 2H(t, 8.79652~8.75836), 1H(d, 8.43321~8.41521), 1H(d, 8.39897~8.38319), 3H(m, 7.99875~7.94919), 2H(m, 7.91587~7.87968), 1H(s, 7.84221), 2H(t, 7.75157~7.71635), 2H(m, 7.69022~7.66037), 3H(t, 7.59199~7.55978), 5H(m, 7.43712~7.38316), 1H(d, 7.33532~7.30987), 1H(d, 7.28712~7.25621), 4H(m, 7.17623~7.10643), 1H(d, 7.03213~7.01556), 1H(d, 6.98097~6.96463), 1H(d, 6.58013~6.56302), 3H(s, 2.75243) 1 H NMR (CDCl 3 , 500 MHz): 2H (t, 8.79652-8.75836), 1H (d, 8.43321-8.41521), 1H (d, 8.39897-8.38319), 3H (m, 7.99875-7.94919), 2H (m, 7.91587-7.87968), 1H (s, 7.84221), 2H (t, 7.75157 ~ 7.71635), 2H (m, 7.69022 ~ 7.66037), 3H (t, 7.59199 ~ 7.55978), 5H (m, 7.43712 ~ 7.38316), 1H ( d, 7.33532 ~ 7.30987), 1H (d, 7.28712 ~ 7.25621), 4H (m, 7.17623 ~ 7.10643), 1H (d, 7.03213 ~ 7.01556), 1H (d, 6.98097 ~ 6.96463), 1H (d, 6.58013 ~ 6.56302 ), 3H (s, 2.75243)

EI-MS : m/z 683(M+)EI-MS: m / z 683 (M +)

5-6) 화합물 260의 합성5-6) Synthesis of Compound 260

100ml 3구 둥근바닥플라스크에 중간체 16(10 g), 4-(1-나프탈렌)-1-페닐보론산(4.7 g), 테트라하이드로퓨란(100 ml), 탄산칼륨(3.9 g) 및 물(40 ml)을 넣고 교반하였다. 이 혼합액에 테트라키스(트리페닐포스핀)팔라듐(0)(1.1 g)을 넣고 80℃로 가열하였다. 반응액을 냉각한 후 여과하고 결정을 아세톤으로 씻어준 후 염화메틸렌으로 재결정하여 표제 화합물 12 g을 얻었다.In a 100 ml three-necked round bottom flask, intermediate 16 (10 g), 4- (1-naphthalene) -1-phenylboronic acid (4.7 g), tetrahydrofuran (100 ml), potassium carbonate (3.9 g) and water (40) ml) was added and stirred. Tetrakis (triphenylphosphine) palladium (0) (1.1 g) was added to this mixed solution, and it heated at 80 degreeC. The reaction solution was cooled, filtered and the crystals were washed with acetone and recrystallized with methylene chloride to obtain 12 g of the title compound.

1H NMR(CDCl3, 500MHz) : 1H(d, 8.48257~8.46562), 1H(d, 8.40254~8.38596), 1H(d, 8.05832~8.04220), 2H(d, 8.00324~7.98666), 1H(d, 7.97954~7.96394), 3H(m, 94291~7.88471), 1H(d, 7.86588~7.84936), 5H(m, 7.60124~7.61055), 6H(m, 7.56555~7.48242), 4H(m, 7.44577~7.38305), 1H(t, 7.31357~7.29255), 4H(7.18356~7.12363), 1H(d, 7.09144~7.07529), 1H(d, 6.65264~6.63775), 3H(s, 2.68341) 1 H NMR (CDCl 3 , 500 MHz): 1H (d, 8.48257-8.46562), 1H (d, 8.40254-8.38596), 1H (d, 8.05832-88.04220), 2H (d, 8.00324-7.98666), 1H (d, 7.97954 ~ 7.96394), 3H (m, 94291 ~ 7.88471), 1H (d, 7.86588 ~ 7.84936), 5H (m, 7.60124 ~ 7.61055), 6H (m, 7.56555 ~ 7.48242), 4H (m, 7.44577 ~ 7.38305), 1H (t, 7.31357 ~ 7.29255), 4H (7.18356 ~ 7.12363), 1H (d, 7.09144 ~ 7.07529), 1H (d, 6.65264 ~ 6.63775), 3H (s, 2.68341)

EI-MS : m/z 709(M+)EI-MS: m / z 709 (M +)

상기 실시예 1 내지 5에서 얻어진 화합물의 용액 중에서의 최대 흡수 파장(UV-Vis spectrum), 최대 발광 파장(PL: Photoluminescence), 유리전이온도(Tg), 녹는점(Tm), 밴드갭(Bg: bandgap), 및 HOMO 및 LUMO 레벨을 측정하여 그 결과를 하기 표 1에 나타내었다. 또한, 실시예 1에서 얻어진 화합물 1의 흡광 및 발광 스펙트럼을 도 1에 나타내었으며, 실시예 3에서 얻어진 화합물 110의 1H-NMR, 질량분석, 흡광 및 발광 스펙트럼, 그리고 열분석 그래프를 도 2 내지 도 5에 각각 나타내었다.Maximum absorption wavelength (UV-Vis spectrum), maximum emission wavelength (PL: Photoluminescence), glass transition temperature (T g ), melting point (T m ), band gap (in the solution of the compounds obtained in Examples 1 to 5) Bg: bandgap), and HOMO and LUMO levels were measured and the results are shown in Table 1 below. In addition, the absorption and emission spectra of Compound 1 obtained in Example 1 are shown in FIG. 1, and 1 H-NMR, mass spectrometry, absorption and emission spectra, and thermal analysis graphs of Compound 110 obtained in Example 3 are shown in FIGS. 5 is shown respectively.

Figure 112009059119266-PAT00029
Figure 112009059119266-PAT00029

<유기전기발광소자의 제조><Production of Organic Electroluminescent Device>

실시예 6Example 6

박막 두께가 150 nm인 ITO(인듐 주석 산화물) 투명 전극 라인을 갖는, 40 mm ㅧ 40 mm ㅧ 0.7 mm 크기의 유리 기판을 세제가 용해된 증류수 속에서 10분 동안 초음파로 세정하고, 증류수에서 10분 동안 2 회 반복 세정하였다. 증류수 세정이 끝나면 이소프로필알코올, 아세톤, 메탄올 등의 용제를 사용하여 기판을 순차적으로 초음파 세척하고 건조시켰다. 이어, 산소/아르곤 플라즈마를 이용하여 건식세정한 후, 투명 전극 라인을 갖는 유리 기판을 진공 증착 장치의 기판 홀더에 장착하고 투명 전극 라인이 형성되어 있는 면상에, 상기 투명 전극을 덮도록 막 두께 60 nm의 N,N'-다이페닐-N,N'-비스-[4-(페닐-m-톨릴아미노)페닐]-바이페닐-4,4'-다이아민 막(이하, DNTPD 막)을 정공주입층으로서 성막하였다. 다음에, DNTPD 막상에 막 두께 30 nm의 4,4'-비스[N-(1-나프틸)-N-페닐아미노]바이페닐 막(이하, NPB 막)을 정공수송층으로서 성막하였다. 다음에, NPB 막상에 막 두께 20 nm의 상기 화합물 30과 BD-1 [4-(2-(4,4'-페닐바이페닐)비닐)-N,N-디페닐벤젠아민, 하기 구조식 참조]을 각각 발광 호스트 물질 및 도판트 물질로서 100 대 5의 중량비로 증착하여 발광층으로서 성막하였다. 상기 막상에 막 두께 20 nm의 트리스(8-퀴놀리놀)알루미늄 막(이하, Alq 막)을 전자수송층으로서 성막하였다. 이어, 그 위에 LiF을 증착시켜 전자주입층을 형성하였다. 이 LiF 막상에 금속 알루미늄을 증착시켜 금속 음극을 형성하여 유기전기발광소자를 제조하였다. A glass substrate of size 40 mm × 40 mm × 0.7 mm, having an ITO (indium tin oxide) transparent electrode line having a thin film thickness of 150 nm, was ultrasonically cleaned in distilled water with detergent for 10 minutes and 10 minutes in distilled water. The wash was repeated twice. After the distilled water was washed, the substrate was sequentially ultrasonically cleaned and dried using a solvent such as isopropyl alcohol, acetone, and methanol. Subsequently, after dry cleaning using oxygen / argon plasma, the glass substrate having the transparent electrode lines was mounted on the substrate holder of the vacuum deposition apparatus, and the film thickness 60 was formed so as to cover the transparent electrodes on the surface where the transparent electrode lines were formed. Holes in nm N, N' -diphenyl- N, N' -bis- [4- (phenyl- m -tolylamino) phenyl] -biphenyl-4,4'-diamine membrane (hereinafter DNTPD membrane) It formed into a film as an injection layer. Next, a 4,4'-bis [ N- (1-naphthyl) -N -phenylamino] biphenyl film (hereinafter referred to as NPB film) having a thickness of 30 nm was formed on the DNTPD film as a hole transport layer. Next, Compound 30 and BD-1 having a film thickness of 20 nm on NPB film [4- (2- (4,4'-phenylbiphenyl) vinyl) -N, N-diphenylbenzeneamine, see Structural Formula below] Was deposited as a light emitting host material and a dopant material at a weight ratio of 100 to 5, respectively, to form a light emitting layer. A tris (8-quinolinol) aluminum film (hereinafter, Alq film) having a film thickness of 20 nm was formed on the film as an electron transporting layer. Subsequently, LiF was deposited thereon to form an electron injection layer. Metal aluminum was deposited on the LiF film to form a metal cathode, thereby manufacturing an organic electroluminescent device.

상기와 같이 제작된 유기전기발광소자에 대해서, 7 V의 전압으로 측정한 결과 전류밀도가 31.5 mA/cm2로 형성되고, 발광은 1931 CIE 색좌표 기준으로 x=0.13, y=0.14에 해당하는 1229 cd/m2 밝기의 스펙트럼이 관찰되었으며, 발광 효율은 3.9 cd/A 이었다.In the organic electroluminescent device manufactured as described above, a current density of 31.5 mA / cm 2 was measured using a voltage of 7 V, and light emission was 1229 corresponding to x = 0.13 and y = 0.14 based on a 1931 CIE color coordinate. A spectrum of cd / m 2 brightness was observed and the luminous efficiency was 3.9 cd / A.

Figure 112009059119266-PAT00030
BD-1
Figure 112009059119266-PAT00030
BD-1

실시예 7 내지 20 및 비교예 1Examples 7-20 and Comparative Example 1

발광 호스트 물질로서 화합물 30 대신에 하기 표 2에서 나타낸 물질을 사용하는 것을 제외하고는 상기 실시예 6과 동일한 공정을 수행하여 유기전기발광소자를 제작하였다. 비교예 1에 사용된 호스트 재료인 β-ADN은 9,10-다이(나프탈렌-2-일)안트라센이다 (하기 구조식 참조).An organic electroluminescent device was manufactured in the same manner as in Example 6, except that the material shown in Table 2 was used instead of the compound 30 as a light emitting host material. Β-ADN, the host material used in Comparative Example 1, is 9,10-di (naphthalen-2-yl) anthracene (see Structural Formula below).

제작된 유기전기발광소자의 물성 측정결과를 하기 표 2에 나타내었다.The physical property measurement results of the fabricated organic electroluminescent device are shown in Table 2 below.

Figure 112009059119266-PAT00031
β-ADN
Figure 112009059119266-PAT00031
β-ADN

실시예 21Example 21

발광 호스트 물질로서 화합물 30 대신에 β-ADN를 사용하고 발광 도판트 물질로서 BD-1 대신에 화합물 94를 사용하는 것을 제외하고는 상기 실시예 6과 동일한 공정을 수행하여 유기전기발광소자를 제작하였다.An organic electroluminescent device was manufactured in the same manner as in Example 6, except that β-ADN was used instead of Compound 30 as a light emitting host material and Compound 94 was used instead of BD-1 as a light emitting dopant material. .

제작된 유기전기발광소자의 물성 측정결과를 하기 표 2에 나타내었다.The physical property measurement results of the fabricated organic electroluminescent device are shown in Table 2 below.

Figure 112009059119266-PAT00032
Figure 112009059119266-PAT00032

상기 표 2의 결과로부터 알 수 있듯이, 실시예 6 내지 21에서 제조된 본 발명의 유기전기발광소자는 기존 발광 물질을 사용하는 비교예 1의 경우에 비해 향상된 구동전압, 발광효율, 색순도 및 수명 특성을 나타낸다.As can be seen from the results of Table 2, the organic electroluminescent device of the present invention prepared in Examples 6 to 21 has improved driving voltage, luminous efficiency, color purity and lifespan characteristics compared to the case of Comparative Example 1 using a conventional light emitting material Indicates.

실시예 22Example 22

전자수송층 성막시 Alq 대신에 화합물 149를 사용하는 것을 제외하고는 상기 비교예 1과 동일한 공정을 수행하여 유기전기발광소자를 제작하였다.An organic electroluminescent device was manufactured in the same manner as in Comparative Example 1, except that Compound 149 was used instead of Alq when forming the ETL.

상기와 같이 제작된 유기전기발광소자에 대해서, 7 V의 전압으로 측정한 결과 전류밀도가 42.1 mA/cm2로 형성되고, 발광은 1931 CIE 색좌표 기준으로 x=0.13, y=0.14에 해당하는 1895 cd/m2 밝기의 스펙트럼이 관찰되었으며, 발광 효율은 4.5 cd/A 이었다. 이러한 결과는 비교예 1에 비해 월등히 우수한 것으로서 화합물 149가 우수한 전자수송층 재료로서의 역할을 수행할 수 있음을 보여준다.In the organic electroluminescent device manufactured as described above, a current density of 42.1 mA / cm 2 was measured using a voltage of 7 V, and light emission was 1895 corresponding to x = 0.13 and y = 0.14 based on a 1931 CIE color coordinate. A spectrum of cd / m 2 brightness was observed and the luminous efficiency was 4.5 cd / A. These results show that Compound 149 can play a role as an excellent electron transport layer material as being significantly superior to Comparative Example 1.

도 1은 실시예 1에서 얻어진 화합물 1의 흡광 및 발광 스펙트럼이고,1 is an absorption and emission spectrum of Compound 1 obtained in Example 1,

도 2 내지 5는 각각 실시예 3에서 얻어진 화합물 110의 1H-NMR, 질량분석, 흡광 및 발광 스펙트럼, 그리고 열분석 그래프이다.2 to 5 are 1 H-NMR, mass spectrometry, absorption and emission spectra, and thermal analysis graphs of Compound 110 obtained in Example 3, respectively.

Claims (14)

하기 화학식 1로 표시되는 화합물:Compound represented by the following formula (1): [화학식 1][Formula 1]
Figure 112009059119266-PAT00033
Figure 112009059119266-PAT00033
상기 식에서,Where R1 및 R2는 각각 독립적으로 수소, C1-50 알킬, C3-50 사이클로알킬, C6-50 아릴 또는 핵 원자수 5 내지 50개의 헤테로아릴이고, 상기 R1 내지 R2는 임의적으로 C1-50 알킬, C6-50 아릴, 핵 원자수 5 내지 50개의 헤테로아릴 또는 C7-50 아르알킬로 치환될 수 있고, R1과 R2는 임의적으로 서로 결합하여 C4-50 포화 고리 또는 불포화 고리를 형성할 수 있고;R 1 and R 2 are each independently hydrogen, C 1-50 alkyl, C 3-50 cycloalkyl, C 6-50 aryl or heteroaryl having 5 to 50 nuclear atoms, wherein R 1 to R 2 are optionally C 1-50 alkyl, C 6-50 aryl, 5 to 50 heteroaryl or C 7-50 aralkyl may be substituted, and R 1 and R 2 are optionally bonded to each other to C 4-50 saturated May form a ring or an unsaturated ring; Ar은 X로 치환되거나 치환되지 않은, 2개 이상의 벤젠 고리가 접합된 방향족 탄화수소이고; Ar is an aromatic hydrocarbon having two or more benzene rings conjugated or unsubstituted by X; R3 및 X는 각각 독립적으로 수소, 할로겐, 시아노, 니트로, 아미노, 싸이오, 포스포릴, 포스피닐, 카보닐, 실릴, 보란일, C1-50 알킬, C2-50 알케닐, C2-50 알키닐, C1-50 알콕시, C3-50 사이클로알킬, C6-50 아릴 또는 핵 원자수 5 내지 50개의 헤테로아릴이고(단 X는 수소가 아님), 상기 R3 및 X는 임의적으로 C1-6 알킬로 치환되거나 치환되지 않은, 아미노, 싸이오, 카보닐, 실릴, 보란일, C1-50 알킬, C2-50 알케닐, C2-50 알키닐, C1-50 알콕시, C3-50 사이클로알킬, C6-50 아릴, 핵 원자수 5 내지 50개의 헤테로아릴 또는 C7-50 아르알킬로 치환될 수 있고, R3 및 X 각각은 인접한 기와 임의적으로 서로 결합하여 C4-50 포화 고리 또는 불포화 고리를 형성할 수 있고;R 3 and X are each independently hydrogen, halogen, cyano, nitro, amino, thio, phosphoryl, phosphinyl, carbonyl, silyl, boranyl, C 1-50 alkyl, C 2-50 alkenyl, C 2-50 alkynyl, C 1-50 alkoxy, C 3-50 cycloalkyl, C 6-50 aryl or heteroaryl having 5 to 50 nuclear atoms (where X is not hydrogen), wherein R 3 and X are Amino, thio, carbonyl, silyl, boranyl, C 1-50 alkyl, C 2-50 alkenyl, C 2-50 alkynyl, C 1- , optionally substituted with C 1-6 alkyl 50 alkoxy, C 3-50 cycloalkyl, C 6-50 aryl, 5 to 50 heteroaryl or C 7-50 aralkyl, and each of R 3 and X may optionally be bonded to an adjacent group. To form a C 4-50 saturated ring or unsaturated ring; n은 1 내지 6의 정수이다.n is an integer of 1-6.
제 1 항에 있어서,The method of claim 1, 상기 화학식 1의 화합물이 하기 화학식 1a 내지 1h의 화합물 중 어느 하나인 것을 특징으로 하는 화합물:A compound according to claim 1, wherein the compound of Formula 1 is any one of the following Formulas 1a to 1h: [화학식 1a][Formula 1a]
Figure 112009059119266-PAT00034
Figure 112009059119266-PAT00034
[화학식 1b][Chemical Formula 1b]
Figure 112009059119266-PAT00035
Figure 112009059119266-PAT00035
[화학식 1c][Formula 1c]
Figure 112009059119266-PAT00036
Figure 112009059119266-PAT00036
[화학식 1d]&Lt; RTI ID = 0.0 &
Figure 112009059119266-PAT00037
Figure 112009059119266-PAT00037
[화학식 1e][Formula 1e]
Figure 112009059119266-PAT00038
Figure 112009059119266-PAT00038
[화학식 1f][Formula 1f]
Figure 112009059119266-PAT00039
Figure 112009059119266-PAT00039
[화학식 1g][Formula 1g]
Figure 112009059119266-PAT00040
Figure 112009059119266-PAT00040
[화학식 1h][Formula 1h]
Figure 112009059119266-PAT00041
Figure 112009059119266-PAT00041
상기 식에서,Where R1 내지 R3, X 및 n은 제 1 항에서 정의한 바와 같고;R 1 to R 3 , X and n are as defined in claim 1; m은 1 내지 6의 정수이고;m is an integer from 1 to 6; z는 1 내지 8의 정수이다.z is an integer from 1 to 8.
제 1 항에 있어서,The method of claim 1, 상기 화학식 1의 화합물이 하기 화학식 1a의 화합물인 것을 특징으로 하는 화합물:A compound according to claim 1, wherein the compound of Formula 1 is a compound of Formula 1a: [화학식 1a][Formula 1a]
Figure 112009059119266-PAT00042
Figure 112009059119266-PAT00042
상기 식에서,Where R1 내지 R3, X 및 n은 제 1 항에서 정의한 바와 같고;R 1 to R 3 , X and n are as defined in claim 1; m은 1 내지 6의 정수이다.m is an integer of 1-6.
제 1 항에 있어서,The method of claim 1, 상기 화학식 1의 화합물이 하기 화학식 1g의 화합물인 것을 특징으로 하는 화합물:A compound according to claim 1, wherein the compound of formula 1 is a compound of formula 1g: [화학식 1g][Formula 1g]
Figure 112009059119266-PAT00043
Figure 112009059119266-PAT00043
상기 식에서,Where R1 내지 R3, X 및 n은 제 1 항에서 정의한 바와 같고;R 1 to R 3 , X and n are as defined in claim 1; z는 1 내지 8의 정수이다.z is an integer from 1 to 8.
(1) 유기용매와 물의 혼합용매 중에서 하기 화학식 2의 화합물을 하기 화학식 3의 화합물과 반응시켜 하기 화학식 4의 화합물을 제조하고, (1) In a mixed solvent of an organic solvent and water, a compound of formula 2 is reacted with a compound of formula 3 to prepare a compound of formula 4, (2) 화학식 4의 화합물을 유기용매 중에서 염기 존재 하에 하기 화학식 5의 화합물과 반응시켜 하기 화학식 6의 화합물을 제조하고, (2) reacting a compound of formula 4 with a compound of formula 5 in an organic solvent in the presence of a base to prepare a compound of formula 6 (3) 화학식 6의 화합물을 산 존재 하에 고리형성 반응시키는 것을 포함하는,(3) cyclizing the compound of formula 6 in the presence of an acid, 하기 화학식 1i의 화합물의 제조방법:Method for preparing a compound of Formula 1i
Figure 112009059119266-PAT00044
Figure 112009059119266-PAT00044
Figure 112009059119266-PAT00045
Figure 112009059119266-PAT00045
Figure 112009059119266-PAT00046
Figure 112009059119266-PAT00046
Figure 112009059119266-PAT00047
Figure 112009059119266-PAT00047
Figure 112009059119266-PAT00048
Figure 112009059119266-PAT00048
Figure 112009059119266-PAT00049
Figure 112009059119266-PAT00049
상기 식에서,Where R1 및 R2는 각각 독립적으로 수소, C1-50 알킬, C3-50 사이클로알킬, C6-50 아릴 또는 핵 원자수 5 내지 50개의 헤테로아릴이고, 상기 R1 내지 R2는 임의적으로 C1-50 알킬, C6-50 아릴, 핵 원자수 5 내지 50개의 헤테로아릴 또는 C7-50 아르알킬로 치환될 수 있고, R1과 R2는 임의적으로 서로 결합하여 C4-50 포화 고리 또는 불포화 고리를 형성할 수 있고;R 1 and R 2 are each independently hydrogen, C 1-50 alkyl, C 3-50 cycloalkyl, C 6-50 aryl or heteroaryl having 5 to 50 nuclear atoms, wherein R 1 to R 2 are optionally C 1-50 alkyl, C 6-50 aryl, 5 to 50 heteroaryl or C 7-50 aralkyl may be substituted, and R 1 and R 2 are optionally bonded to each other to C 4-50 saturated May form a ring or an unsaturated ring; Ar은 X로 치환되거나 치환되지 않은, 2개 이상의 벤젠 고리가 접합된 방향족 탄화수소이고;Ar is an aromatic hydrocarbon having two or more benzene rings conjugated or unsubstituted by X; X는 할로겐, 시아노, 니트로, 아미노, 싸이오, 포스포릴, 포스피닐, 카보닐, 실릴, 보란일, C1-50 알킬, C2-50 알케닐, C2-50 알키닐, C1-50 알콕시, C3-50 사이클로알킬, C6-50 아릴 또는 핵 원자수 5 내지 50개의 헤테로아릴이고, 상기 X는 임의적으로 C1-6 알킬로 치환되거나 치환되지 않은, 아미노, 싸이오, 카보닐, 실릴, 보란일, C1-50 알킬, C2-50 알케닐, C2-50 알키닐, C1-50 알콕시, C3-50 사이클로알킬, C6-50 아릴, 핵 원자수 5 내지 50개의 헤테로아릴 또는 C7-50 아르알킬로 치환될 수 있고, X는 인접한 기와 임의적으로 서로 결합하여 C4-50 포화 고리 또는 불포화 고리를 형성할 수 있고;X is halogen, cyano, nitro, amino, thio, phosphoryl, phosphinyl, carbonyl, silyl, boranyl, C 1-50 alkyl, C 2-50 alkenyl, C 2-50 alkynyl, C 1 -50 alkoxy, C 3-50 cycloalkyl, C 6-50 aryl or heteroaryl having 5 to 50 nuclear atoms, wherein X is optionally substituted with C 1-6 alkyl, amino, thio, Carbonyl, silyl, boranyl, C 1-50 alkyl, C 2-50 alkenyl, C 2-50 alkynyl, C 1-50 alkoxy, C 3-50 cycloalkyl, C 6-50 aryl, nuclear atom May be substituted with 5 to 50 heteroaryl or C 7-50 aralkyl, and X may optionally combine with adjacent groups to form a C 4-50 saturated or unsaturated ring; X1 및 X2는 각각 독립적으로 트리플루오로메탄설포닐 또는 할로겐이고;X 1 and X 2 are each independently trifluoromethanesulfonyl or halogen; Y1 및 Y2는 각각 독립적으로 수소 또는 C1-6 알킬이고, Y1 및 Y2는 서로 결합하여 고리를 형성할 수 있다.Y 1 and Y 2 are each independently hydrogen or C 1-6 alkyl, and Y 1 and Y 2 may be bonded to each other to form a ring.
(1) 유기용매와 물의 혼합용매 중에서 하기 화학식 2의 화합물을 하기 화학식 3의 화합물과 반응시켜 하기 화학식 4의 화합물을 제조하고, (1) In a mixed solvent of an organic solvent and water, a compound of formula 2 is reacted with a compound of formula 3 to prepare a compound of formula 4, (2) 화학식 4의 화합물을 유기용매 중에서 염기 존재 하에 하기 화학식 5의 화합물과 반응시켜 하기 화학식 6의 화합물을 제조하고, (2) reacting a compound of formula 4 with a compound of formula 5 in an organic solvent in the presence of a base to prepare a compound of formula 6 (3) 화학식 6의 화합물을 산 존재 하에 고리형성 반응시켜 하기 화학식 1i의 화합물을 제조하고, (3) a compound of formula 6i is prepared by cyclization of a compound of formula 6 in the presence of an acid, (4) 화학식 1i의 화합물을 유기용매 중에서 (X3)2와 반응시켜 하기 화학식 7의 화합물을 제조하고, (4) reacting a compound of Formula 1i with (X 3 ) 2 in an organic solvent to produce a compound of Formula 7 (5) 화학식 7의 화합물을 유기용매와 물의 혼합용매 중에서 하기 화학식 8의 화합물과 반응시키는 것을 포함하는,(5) comprising reacting a compound of formula 7 with a compound of formula 8 in a mixed solvent of an organic solvent and water, 하기 화학식 1j의 화합물의 제조방법:To prepare a compound of Formula 1j: [화학식 2][Formula 2]
Figure 112009059119266-PAT00050
Figure 112009059119266-PAT00050
[화학식 3](3)
Figure 112009059119266-PAT00051
Figure 112009059119266-PAT00051
[화학식 4][Formula 4]
Figure 112009059119266-PAT00052
Figure 112009059119266-PAT00052
[화학식 5][Chemical Formula 5]
Figure 112009059119266-PAT00053
Figure 112009059119266-PAT00053
[화학식 6][Formula 6]
Figure 112009059119266-PAT00054
Figure 112009059119266-PAT00054
[화학식 1i]Formula 1i]
Figure 112009059119266-PAT00055
Figure 112009059119266-PAT00055
Figure 112009059119266-PAT00056
Figure 112009059119266-PAT00056
Figure 112009059119266-PAT00057
Figure 112009059119266-PAT00057
Figure 112009059119266-PAT00058
Figure 112009059119266-PAT00058
상기 식에서,Where R1 및 R2는 각각 독립적으로 수소, C1-50 알킬, C3-50 사이클로알킬, C6-50 아릴 또는 핵 원자수 5 내지 50개의 헤테로아릴이고, 상기 R1 내지 R2는 임의적으로 C1-50 알킬, C6-50 아릴, 핵 원자수 5 내지 50개의 헤테로아릴 또는 C7-50 아르알킬로 치환될 수 있고, R1과 R2는 임의적으로 서로 결합하여 C4-50 포화 고리 또는 불포화 고리를 형성할 수 있고;R 1 and R 2 are each independently hydrogen, C 1-50 alkyl, C 3-50 cycloalkyl, C 6-50 aryl or heteroaryl having 5 to 50 nuclear atoms, wherein R 1 to R 2 are optionally C 1-50 alkyl, C 6-50 aryl, 5 to 50 heteroaryl or C 7-50 aralkyl may be substituted, and R 1 and R 2 are optionally bonded to each other to C 4-50 saturated May form a ring or an unsaturated ring; Ar은 X로 치환되거나 치환되지 않은, 2개 이상의 벤젠 고리가 접합된 방향족 탄화수소이고; Ar is an aromatic hydrocarbon having two or more benzene rings conjugated or unsubstituted by X; R3' 및 X는 각각 독립적으로 할로겐, 시아노, 니트로, 아미노, 싸이오, 포스포릴, 포스피닐, 카보닐, 실릴, 보란일, C1-50 알킬, C2-50 알케닐, C2-50 알키닐, C1-50 알콕시, C3-50 사이클로알킬, C6-50 아릴 또는 핵 원자수 5 내지 50개의 헤테로아릴이고, 상기 R3' 및 X는 임의적으로 C1-6 알킬로 치환되거나 치환되지 않은, 아미노, 싸이오, 카보닐, 실릴, 보란일, C1-50 알킬, C2-50 알케닐, C2-50 알키닐, C1-50 알콕시, C3-50 사이클로알킬, C6-50 아릴, 핵 원자수 5 내지 50개의 헤테로아릴 또는 C7-50 아르알킬로 치환될 수 있고, R3' 및 X 각각은 인접한 기와 임의적으로 서로 결합하여 C4-50 포화 고리 또는 불포화 고리를 형성할 수 있고;R 3 ′ and X are each independently halogen, cyano, nitro, amino, thio, phosphoryl, phosphinyl, carbonyl, silyl, boranyl, C 1-50 alkyl, C 2-50 alkenyl, C 2 -50 alkynyl, C 1-50 alkoxy, C 3-50 cycloalkyl, C 6-50 aryl or heteroaryl having 5 to 50 nuclear atoms, wherein R 3 ′ and X are optionally C 1-6 alkyl Substituted or unsubstituted amino, thio, carbonyl, silyl, boranyl, C 1-50 alkyl, C 2-50 alkenyl, C 2-50 alkynyl, C 1-50 alkoxy, C 3-50 cyclo Alkyl, C 6-50 aryl, heteroaryl having 5 to 50 nuclear atoms, or C 7-50 aralkyl, each of R 3 ′ and X optionally bonded to one another with an adjacent group to form a C 4-50 saturated ring Or may form an unsaturated ring; X1 및 X2는 각각 독립적으로 트리플루오로메탄설포닐 또는 할로겐이고;X 1 and X 2 are each independently trifluoromethanesulfonyl or halogen; X3는 할로겐이고;X 3 is halogen; Y1 및 Y2는 각각 독립적으로 수소 또는 C1-6 알킬이고, Y1 및 Y2는 서로 결합하여 고리를 형성할 수 있다.Y 1 and Y 2 are each independently hydrogen or C 1-6 alkyl, and Y 1 and Y 2 may be bonded to each other to form a ring.
(1) 유기용매와 물의 혼합용매 중에서 하기 화학식 9의 화합물을 하기 화학식 10의 화합물과 반응시켜 하기 화학식 11의 화합물을 제조하고, (1) In a mixed solvent of an organic solvent and water to react the compound of formula 9 with a compound of formula 10 to prepare a compound of formula 11 (2) 화학식 11의 화합물을 유기용매 중에서 염기 존재 하에 하기 화학식 5의 화합물과 반응시켜 하기 화학식 12의 화합물을 제조하고, (2) preparing a compound of formula 12 by reacting a compound of formula 11 with a compound of formula 5 in an organic solvent in the presence of a base: (3) 화학식 12의 화합물을 산 존재 하에 고리형성 반응시키는 것을 포함하는,(3) cyclizing the compound of formula 12 in the presence of an acid, 하기 화학식 1k의 화합물의 제조방법:Method for preparing a compound of Formula 1k
Figure 112009059119266-PAT00059
Figure 112009059119266-PAT00059
Figure 112009059119266-PAT00060
Figure 112009059119266-PAT00060
Figure 112009059119266-PAT00061
Figure 112009059119266-PAT00061
[화학식 5][Chemical Formula 5]
Figure 112009059119266-PAT00062
Figure 112009059119266-PAT00062
Figure 112009059119266-PAT00063
Figure 112009059119266-PAT00063
Figure 112009059119266-PAT00064
Figure 112009059119266-PAT00064
상기 식에서,Where R1 및 R2는 각각 독립적으로 수소, C1-50 알킬, C3-50 사이클로알킬, C6-50 아릴 또는 핵 원자수 5 내지 50개의 헤테로아릴이고, 상기 R1 내지 R2는 임의적으로 C1-50 알킬, C6-50 아릴, 핵 원자수 5 내지 50개의 헤테로아릴 또는 C7-50 아르알킬로 치환될 수 있고, R1과 R2는 임의적으로 서로 결합하여 C4-50 포화 고리 또는 불포화 고리를 형성할 수 있고;R 1 and R 2 are each independently hydrogen, C 1-50 alkyl, C 3-50 cycloalkyl, C 6-50 aryl or heteroaryl having 5 to 50 nuclear atoms, wherein R 1 to R 2 are optionally C 1-50 alkyl, C 6-50 aryl, 5 to 50 heteroaryl or C 7-50 aralkyl may be substituted, and R 1 and R 2 are optionally bonded to each other to C 4-50 saturated May form a ring or an unsaturated ring; Ar은 X로 치환되거나 치환되지 않은, 2개 이상의 벤젠 고리가 접합된 방향족 탄화수소이고;Ar is an aromatic hydrocarbon having two or more benzene rings conjugated or unsubstituted by X; R3' 및 X는 각각 독립적으로 할로겐, 시아노, 니트로, 아미노, 싸이오, 포스포릴, 포스피닐, 카보닐, 실릴, 보란일, C1-50 알킬, C2-50 알케닐, C2-50 알키닐, C1-50 알콕시, C3-50 사이클로알킬, C6-50 아릴 또는 핵 원자수 5 내지 50개의 헤테로아릴이고, 상기 R3' 및 X는 임의적으로 C1-6 알킬로 치환되거나 치환되지 않은, 아미노, 싸이오, 카보닐, 실릴, 보란일, C1-50 알킬, C2-50 알케닐, C2-50 알키닐, C1-50 알콕시, C3-50 사이클로알킬, C6-50 아릴, 핵 원자수 5 내지 50개의 헤테로아릴 또는 C7-50 아르알킬로 치환될 수 있고, R3' 및 X 각각은 인접한 기와 임의적으로 서로 결합하여 C4-50 포화 고리 또는 불포화 고리를 형성할 수 있고;R 3 ′ and X are each independently halogen, cyano, nitro, amino, thio, phosphoryl, phosphinyl, carbonyl, silyl, boranyl, C 1-50 alkyl, C 2-50 alkenyl, C 2 -50 alkynyl, C 1-50 alkoxy, C 3-50 cycloalkyl, C 6-50 aryl or heteroaryl having 5 to 50 nuclear atoms, wherein R 3 ′ and X are optionally C 1-6 alkyl Substituted or unsubstituted amino, thio, carbonyl, silyl, boranyl, C 1-50 alkyl, C 2-50 alkenyl, C 2-50 alkynyl, C 1-50 alkoxy, C 3-50 cyclo Alkyl, C 6-50 aryl, heteroaryl having 5 to 50 nuclear atoms, or C 7-50 aralkyl, each of R 3 ′ and X optionally bonded to one another with an adjacent group to form a C 4-50 saturated ring Or may form an unsaturated ring; X1 및 X2는 각각 독립적으로 트리플루오로메탄설포닐 또는 할로겐이고;X 1 and X 2 are each independently trifluoromethanesulfonyl or halogen; Y1 및 Y2는 각각 독립적으로 수소 또는 C1-6 알킬이고, Y1 및 Y2는 서로 결합하여 고리를 형성할 수 있다.Y 1 and Y 2 are each independently hydrogen or C 1-6 alkyl, and Y 1 and Y 2 may be bonded to each other to form a ring.
(1) 유기용매와 물의 혼합용매 중에서 하기 화학식 9의 화합물을 하기 화학식 10의 화합물과 반응시켜 하기 화학식 11의 화합물을 제조하고, (1) In a mixed solvent of an organic solvent and water to react the compound of formula 9 with a compound of formula 10 to prepare a compound of formula 11 (2) 화학식 11의 화합물을 유기용매 중에서 염기 존재 하에 하기 화학식 5의 화합물과 반응시켜 하기 화학식 12의 화합물을 제조하고, (2) preparing a compound of formula 12 by reacting a compound of formula 11 with a compound of formula 5 in an organic solvent in the presence of a base: (3) 화학식 12의 화합물을 산 존재 하에 고리형성 반응시켜 화학식 1k의 화합물을 제조하고, (3) preparing a compound of formula 1k by cyclizing the compound of formula 12 in the presence of an acid, (4) 화학식 1k의 화합물을 유기용매 중에서 (X3)2와 반응시켜 하기 화학식 13의 화합물을 제조하고, (4) reacting a compound of Formula 1k with (X 3 ) 2 in an organic solvent to prepare a compound of Formula 13 (5) 화학식 13의 화합물을 유기용매와 물의 혼합용매 중에서 하기 화학식 14의 화합물과 반응시키는 것을 포함하는,(5) comprising reacting a compound of formula 13 with a compound of formula 14 in a mixed solvent of an organic solvent and water, 하기 화학식 1l의 화합물의 제조방법:To prepare a compound of formula [화학식 9][Formula 9]
Figure 112009059119266-PAT00065
Figure 112009059119266-PAT00065
[화학식 10][Formula 10]
Figure 112009059119266-PAT00066
Figure 112009059119266-PAT00066
[화학식 11][Formula 11]
Figure 112009059119266-PAT00067
Figure 112009059119266-PAT00067
[화학식 5][Chemical Formula 5]
Figure 112009059119266-PAT00068
Figure 112009059119266-PAT00068
[화학식 12][Formula 12]
Figure 112009059119266-PAT00069
Figure 112009059119266-PAT00069
[화학식 1k][Formula 1k]
Figure 112009059119266-PAT00070
Figure 112009059119266-PAT00070
Figure 112009059119266-PAT00071
Figure 112009059119266-PAT00071
Figure 112009059119266-PAT00072
Figure 112009059119266-PAT00072
Figure 112009059119266-PAT00073
Figure 112009059119266-PAT00073
상기 식에서,Where R1 및 R2는 각각 독립적으로 수소, C1-50 알킬, C3-50 사이클로알킬, C6-50 아릴 또는 핵 원자수 5 내지 50개의 헤테로아릴이고, 상기 R1 내지 R2는 임의적으로 C1-50 알킬, C6-50 아릴, 핵 원자수 5 내지 50개의 헤테로아릴 또는 C7-50 아르알킬로 치환될 수 있고, R1과 R2는 임의적으로 서로 결합하여 C4-50 포화 고리 또는 불포화 고리를 형성할 수 있고;R 1 and R 2 are each independently hydrogen, C 1-50 alkyl, C 3-50 cycloalkyl, C 6-50 aryl or heteroaryl having 5 to 50 nuclear atoms, wherein R 1 to R 2 are optionally C 1-50 alkyl, C 6-50 aryl, 5 to 50 heteroaryl or C 7-50 aralkyl may be substituted, and R 1 and R 2 are optionally bonded to each other to C 4-50 saturated May form a ring or an unsaturated ring; Ar은 X로 치환되거나 치환되지 않은, 2개 이상의 벤젠 고리가 접합된 방향족 탄화수소이고;Ar is an aromatic hydrocarbon having two or more benzene rings conjugated or unsubstituted by X; R3', R3" 및 X는 각각 독립적으로 할로겐, 시아노, 니트로, 아미노, 싸이오, 포스포릴, 포스피닐, 카보닐, 실릴, 보란일, C1-50 알킬, C2-50 알케닐, C2-50 알키닐, C1-50 알콕시, C3-50 사이클로알킬, C6-50 아릴 또는 핵 원자수 5 내지 50개의 헤테로아릴이고, 상기 R3', R3" 및 X는 임의적으로 C1-6 알킬로 치환되거나 치환되지 않은, 아미노, 싸이오, 카보닐, 실릴, 보란일, C1-50 알킬, C2-50 알케닐, C2-50 알키닐, C1-50 알콕시, C3-50 사이클로알킬, C6-50 아릴, 핵 원자수 5 내지 50개의 헤테로아릴 또는 C7-50 아르알킬로 치환될 수 있고, R3', R3" 및 X 각각은 인접한 기와 임의적으로 서로 결합하여 C4-50 포화 고리 또는 불포화 고리를 형성할 수 있고;R 3 ′, R 3 ″ and X are each independently halogen, cyano, nitro, amino, thio, phosphoryl, phosphinyl, carbonyl, silyl, boranyl, C 1-50 alkyl, C 2-50 al Kenyl, C 2-50 alkynyl, C 1-50 alkoxy, C 3-50 cycloalkyl, C 6-50 aryl or heteroaryl having 5 to 50 nuclear atoms, wherein R 3 ′, R 3 ″ and X are Amino, thio, carbonyl, silyl, boranyl, C 1-50 alkyl, C 2-50 alkenyl, C 2-50 alkynyl, C 1- , optionally substituted with C 1-6 alkyl 50 alkoxy, C 3-50 cycloalkyl, C 6-50 aryl, 5 to 50 heteroaryl or C 7-50 aralkyl, and R 3 ′, R 3 ″ and X are each adjacent May optionally be combined with one another to form a C 4-50 saturated ring or unsaturated ring; X1 및 X2는 각각 독립적으로 트리플루오로메탄설포닐 또는 할로겐이고;X 1 and X 2 are each independently trifluoromethanesulfonyl or halogen; X3는 할로겐이고;X 3 is halogen; Y1 및 Y2는 각각 독립적으로 수소 또는 C1-6 알킬이고, Y1 및 Y2는 서로 결합하여 고리를 형성할 수 있다.Y 1 and Y 2 are each independently hydrogen or C 1-6 alkyl, and Y 1 and Y 2 may be bonded to each other to form a ring.
양극, 음극, 및 상기 두 전극 사이에 제 1 항의 화합물을 함유하는 하나 이상의 유기층을 포함하는 유기전기발광소자.An organic electroluminescent device comprising an anode, a cathode, and at least one organic layer containing the compound of claim 1 between the two electrodes. 제 9 항에 있어서,The method of claim 9, 상기 유기층이 정공주입층, 정공수송층, 발광층, 전자수송층, 전자주입층 또는 이들의 적층체인 것을 특징으로 하는 유기전기발광소자.And the organic layer is a hole injection layer, a hole transport layer, a light emitting layer, an electron transport layer, an electron injection layer or a laminate thereof. 제 9 항에 있어서,The method of claim 9, 상기 유기층이 발광층인 것을 특징으로 하는 유기전기발광소자.The organic electroluminescent device, characterized in that the organic layer is a light emitting layer. 제 11 항에 있어서,The method of claim 11, 상기 제 1 항의 화합물이 발광 호스트 물질 또는 도판트 물질로서 사용되는 것을 특징으로 하는 유기전기발광소자.An organic electroluminescent device according to claim 1, wherein the compound of claim 1 is used as a light emitting host material or a dopant material. 제 9 항에 있어서,The method of claim 9, 상기 유기층이 전자수송층인 것을 특징으로 하는 유기전기발광소자.The organic electroluminescent device, characterized in that the organic layer is an electron transport layer. 제 10 항에 있어서,The method of claim 10, 양극, 정공주입층, 정공수송층, 발광층, 전자수송층, 전자주입층 및 음극이 순차적으로 적층된 구조를 갖는 것을 특징으로 하는 유기전기발광소자.An organic electroluminescent device comprising a structure in which an anode, a hole injection layer, a hole transport layer, a light emitting layer, an electron transport layer, an electron injection layer, and a cathode are sequentially stacked.
KR1020090091136A 2008-09-30 2009-09-25 Novel aromatic derivatives and organic electroluminescent device comprising same KR101142056B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR1020080096011 2008-09-30
KR20080096011 2008-09-30

Publications (2)

Publication Number Publication Date
KR20100036961A true KR20100036961A (en) 2010-04-08
KR101142056B1 KR101142056B1 (en) 2012-05-03

Family

ID=42073992

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020090091136A KR101142056B1 (en) 2008-09-30 2009-09-25 Novel aromatic derivatives and organic electroluminescent device comprising same

Country Status (2)

Country Link
KR (1) KR101142056B1 (en)
WO (1) WO2010038956A2 (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014058232A2 (en) * 2012-10-10 2014-04-17 대주전자재료 주식회사 Spiro-type organic material, and organic electroluminescent device using same
KR101482632B1 (en) * 2012-10-10 2015-01-15 대주전자재료 주식회사 Spyro type organic material and organic electroluminescent device and organic eletroluminescent device utilizing the same
KR20190055685A (en) * 2017-11-15 2019-05-23 난징고광반도체재료유한회사 Blue host material, organic electroluminescence device and application thereof

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103102299B (en) * 2012-11-12 2015-08-05 吉林奥来德光电材料股份有限公司 A kind of benzanthrene derivative, its preparation method and the electroluminescent organic material be made up of it
CN103805167B (en) * 2012-11-14 2015-12-02 吉林奥来德光电材料股份有限公司 Organic blue luminescent material and its preparation method and application
CN103805166B (en) * 2012-11-14 2015-12-02 吉林奥来德光电材料股份有限公司 Benzanthracenes luminous organic material and its preparation method and application
CN103113281A (en) * 2012-11-14 2013-05-22 吉林奥来德光电材料股份有限公司 Benzanthracene efficient organic light emitting material and preparation method
KR102273046B1 (en) 2014-07-04 2021-07-06 삼성디스플레이 주식회사 Condensed-cyclic compound and organic light emitting diode comprising the same
CN106544009B (en) * 2016-10-18 2018-05-18 中节能万润股份有限公司 A kind of electroluminescent organic material with dibenzofuran structure and preparation method thereof and its application
CN109111461B (en) * 2017-06-22 2021-09-10 北京鼎材科技有限公司 Novel compound and application thereof in electroluminescent device
CN107353285A (en) * 2017-07-28 2017-11-17 长春海谱润斯科技有限公司 A kind of electron transport material, synthetic method and its organic electroluminescence device
CN107266440A (en) * 2017-07-28 2017-10-20 长春海谱润斯科技有限公司 A kind of electron transport material, synthetic method and its organic luminescent device
CN110734381B (en) * 2018-07-18 2023-01-13 江苏三月科技股份有限公司 Compound with triarylamine as core and preparation method and application thereof
JP7456076B2 (en) * 2019-09-30 2024-03-27 国立大学法人群馬大学 Compound, method for producing compound, and organic light emitting device
JPWO2021177144A1 (en) * 2020-03-04 2021-09-10

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007119454A (en) * 2005-09-30 2007-05-17 Chisso Corp Phenalene compound
CN101356211A (en) * 2005-11-11 2009-01-28 住友化学株式会社 Conjugated polymeric compound and polymeric electroluminescence element using the same
DE102006035035A1 (en) * 2006-07-28 2008-01-31 Merck Patent Gmbh New materials for organic electroluminescent devices
KR20080039763A (en) * 2006-11-01 2008-05-07 삼성전자주식회사 Organic light emitting compound and organic light emitting device comprising the same
JP5018138B2 (en) * 2007-03-02 2012-09-05 Jnc株式会社 Luminescent material and organic electroluminescent device using the same

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014058232A2 (en) * 2012-10-10 2014-04-17 대주전자재료 주식회사 Spiro-type organic material, and organic electroluminescent device using same
KR101482632B1 (en) * 2012-10-10 2015-01-15 대주전자재료 주식회사 Spyro type organic material and organic electroluminescent device and organic eletroluminescent device utilizing the same
WO2014058232A3 (en) * 2012-10-10 2015-04-30 대주전자재료 주식회사 Spiro-type organic material, and organic electroluminescent device using same
KR20190055685A (en) * 2017-11-15 2019-05-23 난징고광반도체재료유한회사 Blue host material, organic electroluminescence device and application thereof

Also Published As

Publication number Publication date
WO2010038956A2 (en) 2010-04-08
WO2010038956A3 (en) 2010-07-22
KR101142056B1 (en) 2012-05-03

Similar Documents

Publication Publication Date Title
KR101142056B1 (en) Novel aromatic derivatives and organic electroluminescent device comprising same
KR101775521B1 (en) Organic electroluminescent device
JP5685832B2 (en) Dibenzo [g, p] chrysene compound, light emitting layer material containing the compound, and organic electroluminescence device using the same
CN107011248B (en) Compound and organic electronic device thereof
JP2006045503A (en) Luminescent material and organic electroluminescent element using the same
KR20100007552A (en) Asymmetric anthracene derivatives and electroluminescent devices comprising same
TW201238955A (en) Nitrogenated heterocyclic derivative, electron-transporting material for organic electroluminescent elements, and organic electroluminescent element using same
KR20120020901A (en) Novel compounds for organic electronic material and organic electroluminescent device using the same
KR101415734B1 (en) Hole transporting material using new arylamine and organic electroluminescent device comprising the same
KR20140125061A (en) An organoelectro luminescent compound and an organoelectroluminescent device using the same
KR101334204B1 (en) A New Pyrene Compounds, Method of Producing the Same and Organic Electroluminescent Device Comprising the Same
JP2015216245A (en) Compound for organic electroluminescent element and organic electroluminescent element using the same
KR101321988B1 (en) Aromatic derivatives and organic electroluminescent device comprising same
KR101375542B1 (en) Hole transporting material comprising thiophen derivative and organic electroluminescent device using the same
JP2008308487A (en) BENZO[a]FLUORANTHENE COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE USING THE SAME
KR20140127705A (en) Pyridine-Pyrimidine derivatives and organic electroluminescent device comprising same
KR101327301B1 (en) Amine derivative as hole transporting material and organic electroluminescent device using the same
CN116731060A (en) Aromatic organic compound containing silicon and organic electroluminescent device containing same
KR20130084825A (en) Asymmetric aryl amine structure of the blue light-emitting material containing meta-substituted phenyl and organic electroluminescent device using the its derivatives
JP2016150920A (en) Compound for organic electroluminescent element and organic electroluminescent element using the same
KR20140127702A (en) 2-(phenylsulfonyl)pyridine derivatives and Organic electroluminescent device comprising same
KR100754474B1 (en) Anthracene based organic luminescent compound and organic light-emitting diode including the same
KR20150044592A (en) Method of preparing amine compound
JP6498243B2 (en) Compound and organic electronic device using the same
JP6539821B2 (en) Compound and organic electronic device using the same

Legal Events

Date Code Title Description
A201 Request for examination
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 20150424

Year of fee payment: 4

FPAY Annual fee payment

Payment date: 20160422

Year of fee payment: 5

FPAY Annual fee payment

Payment date: 20170421

Year of fee payment: 6

FPAY Annual fee payment

Payment date: 20180425

Year of fee payment: 7